<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="iso-abbrev">Front Mol Neurosci</journal-id>
<journal-id journal-id-type="publisher-id">Front. Mol. Neurosci.</journal-id>
<journal-title-group>
<journal-title>Frontiers in Molecular Neuroscience</journal-title>
</journal-title-group>
<issn pub-type="epub">1662-5099</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">28507505</article-id>
<article-id pub-id-type="pmc">5410569</article-id>
<article-id pub-id-type="doi">10.3389/fnmol.2017.00112</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Neuroscience</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Protein-Protein Interaction Among the FoxP Family Members and their Regulation of Two Target Genes, <italic>VLDLR</italic> and <italic>CNTNAP2</italic> in the Zebra Finch Song System</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Mendoza</surname>
<given-names>Ezequiel</given-names>
</name>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<xref ref-type="author-notes" rid="fn002">
<sup>†</sup>
</xref>
<uri xlink:href="http://loop.frontiersin.org/people/80422/overview" xlink:type="simple"></uri>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Scharff</surname>
<given-names>Constance</given-names>
</name>
<uri xlink:href="http://loop.frontiersin.org/people/455/overview" xlink:type="simple"></uri>
<xref ref-type="aff" rid="aff1"></xref>
</contrib>
</contrib-group>
<aff id="aff1">
<institution>Institut für Verhaltensbiologie, Freie Universität Berlin</institution>
<country>Berlin, Germany</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Ildikó Rácz, University Hospital Bonn, Germany</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Erich David Jarvis, Duke University, USA; Yonghe Wu, German Cancer Research Center (DKFZ), Germany</p>
</fn>
<corresp id="fn001">*Correspondence: Ezequiel Mendoza <email xlink:type="simple">emendoza@zedat.fu-berlin.de</email></corresp>
<fn fn-type="other" id="fn002">
<p><sup>†</sup>Present address: Ezequiel Mendoza Takustrasse 6, 14193 Berlin, Germany</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>5</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>10</volume>
<elocation-id>112</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>12</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>05</day>
<month>4</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright © 2017 Mendoza and Scharff.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Mendoza and Scharff</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p>
</license>
</permissions>
<abstract>
<p>The Forkhead transcription factor FOXP2 is implicated in speech perception and production. The avian homolog, FoxP2<xref ref-type="fn" rid="fn0001"><sup>1</sup></xref> contributes to song learning and production in birds. In human cell lines, transcriptional activity of FOXP2 requires homo-dimerization or dimerization with paralogs FOXP1 or FOXP4. Whether FoxP dimerization occurs in the brain is unknown. We recently showed that FoxP1, FoxP2 and FoxP4 (FoxP1/2/4) proteins are co-expressed in neurons of Area X, a song control region in zebra finches. We now report on dimer- and oligomerization of zebra finch FoxPs and how this affects transcription. In cell lines and in the brain we identify homo- and hetero-dimers, and an oligomer composed of FoxP1/2/4. We further show that FoxP1/2 but not FoxP4 bind to the regulatory region of the target gene Contactin-associated protein-like 2 (<italic>CNTNAP2</italic>). In addition, we demonstrate that FoxP1/4 bind to the regulatory region of very low density lipoprotein receptor (<italic>VLDLR</italic>), as has been shown for FoxP2 previously. Interestingly, FoxP1/2/4 individually or in combinations regulate the promoters for SV40, zebra finch <italic>VLDLR</italic> and <italic>CNTNAP2</italic> differentially. These data exemplify the potential for complex transcriptional regulation of FoxP1/2/4, highlighting the need for future functional studies dissecting their differential regulation in the brain.</p>
</abstract>
<kwd-group>
<kwd>FoxP2</kwd>
<kwd>FoxP1</kwd>
<kwd>FoxP4</kwd>
<kwd>protein interactions</kwd>
<kwd>transcription factors</kwd>
<kwd>speech</kwd>
<kwd>forkhead transcription factors</kwd>
<kwd>zebra finch</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source id="cn001">Consejo Nacional de Ciencia y Tecnologà­a<named-content content-type="fundref-id">10.13039/501100003141</named-content></funding-source>
<award-id rid="cn001">182509</award-id>
</award-group>
<award-group>
<funding-source id="cn002">Deutsche Forschungsgemeinschaft<named-content content-type="fundref-id">10.13039/501100001659</named-content></funding-source>
<award-id rid="cn002">SFB665</award-id>
</award-group>
</funding-group>
<counts>
<fig-count count="8"></fig-count>
<table-count count="1"></table-count>
<equation-count count="0"></equation-count>
<ref-count count="98"></ref-count>
<page-count count="15"></page-count>
<word-count count="11699"></word-count>
</counts>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="introduction">
<title>Introduction</title>
<p>Forkhead box (Fox) transcription factors comprise 19 highly evolutionary conserved, structurally related families, FoxA to FoxS. The defining feature of these genes is the Fox domain which binds to regulatory regions of target genes. Many <italic>Fox</italic> genes perform tissue specific functions during development and mutations can cause cancer and other diseases (Hannenhalli and Kaestner, <xref ref-type="bibr" rid="B31">2009</xref>).</p>
<p>The FoxP family consists of only one member in invertebrates (Santos et al., <xref ref-type="bibr" rid="B70">2011</xref>). Gene duplication gave rise to four <italic>FoxP</italic> subfamily members in vertebrates, <italic>FoxP1</italic> to <italic>FoxP4</italic> (Song et al., <xref ref-type="bibr" rid="B77">2016</xref>). Expression of these four proteins is specific to particular organs and cell types, with partly overlapping patterns (Lu et al., <xref ref-type="bibr" rid="B45">2002</xref>; Ferland et al., <xref ref-type="bibr" rid="B23">2003</xref>; Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>; Spaeth et al., <xref ref-type="bibr" rid="B78">2015</xref>). FoxP1/2/4 are all expressed in the brain (Lu et al., <xref ref-type="bibr" rid="B45">2002</xref>; Teufel et al., <xref ref-type="bibr" rid="B84">2003</xref>), whereas FoxP3 is prominently expressed in T regulatory cells of the immune system (Huehn et al., <xref ref-type="bibr" rid="B35">2009</xref>).</p>
<p>In humans, <italic>FOXP1</italic> and <italic>FOXP2</italic> mutations impair speech production and perception (Bacon and Rappold, <xref ref-type="bibr" rid="B2">2012</xref>). FoxP1 has also been linked to autism spectrum disorder (ASD; Girirajan et al., <xref ref-type="bibr" rid="B26">2011</xref>; Bowers and Konopka, <xref ref-type="bibr" rid="B7">2012</xref>). A human FOXP4 mutation was associated with developmental delay, heart and larynx problems (Charng et al., <xref ref-type="bibr" rid="B13">2016</xref>).</p>
<p>We study FoxP proteins in songbirds because birdsong and speech share many features (Doupe and Kuhl, <xref ref-type="bibr" rid="B21">1999</xref>). Humans and songbirds learn a large fraction of the sounds they use to communicate through auditory-guided vocal imitation. Vocal production learning of speech and birdsong is constrained by innate predispositions, speech and song learning is best achieved during critical developmental periods and strongly affected by social factors. Birdsong and speech depend on analogous neural pathways that are functionally lateralized (Petkov and Jarvis, <xref ref-type="bibr" rid="B63">2012</xref>; Pfenning et al., <xref ref-type="bibr" rid="B64">2014</xref>). Because of the many parallels between the development of birdsong and speech, songbirds provide a genuine model for behavioral, neural and molecular analyses of genes in the context of vocal communication (Bolhuis et al., <xref ref-type="bibr" rid="B6">2010</xref>). Temporally and spatially precise manipulations of FoxP2 amounts in striatal nucleus Area X, a basal ganglia component of the neural circuit controlling song production and song learning, results in incomplete and inaccurate vocal imitation, alters adult song production, spine density and neural transmission (Haesler et al., <xref ref-type="bibr" rid="B28">2007</xref>; Schulz et al., <xref ref-type="bibr" rid="B71">2010</xref>; Murugan et al., <xref ref-type="bibr" rid="B53">2013</xref>; Heston and White, <xref ref-type="bibr" rid="B32">2015</xref>). The impact of FoxP1 and FoxP4 manipulations on song learning has not been reported, but both FoxPs can co-occur with FoxP2 in the medium spiny neurons (MSNs) of Area X (Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>).</p>
<p>Mice with homozygous deletions of <italic>Foxp1, Foxp2</italic> alone or in combination, or of <italic>Foxp4</italic>, die before or shortly after birth (Li et al., <xref ref-type="bibr" rid="B44">2004b</xref>; Wang et al., <xref ref-type="bibr" rid="B94">2004</xref>; Shu et al., <xref ref-type="bibr" rid="B73">2005</xref>, <xref ref-type="bibr" rid="B74">2007</xref>; Rousso et al., <xref ref-type="bibr" rid="B69">2012</xref>). Heterozygous mutations in mice are associated with deficits in synaptic function, motor behaviors (Groszer et al., <xref ref-type="bibr" rid="B27">2008</xref>; French and Fisher, <xref ref-type="bibr" rid="B24">2014</xref>; Fröhlich et al., <xref ref-type="bibr" rid="B25">2017</xref>) and impact the development and adult production of ultrasonic vocalizations (Castellucci et al., <xref ref-type="bibr" rid="B10">2016</xref>; Chabout et al., <xref ref-type="bibr" rid="B11">2016</xref>). <italic>Foxp4</italic> mouse mutants have numerous brain and spinal cord defects (Rousso et al., <xref ref-type="bibr" rid="B69">2012</xref>).</p>
<p><italic>Drosophila melanogaster</italic> with FoxP mutations or with RNAi mediated manipulations of <italic>FoxP</italic> expression exhibit deficits in an odor-based decision paradigm (DasGupta et al., <xref ref-type="bibr" rid="B18">2014</xref>), in motor coordination and courtship song (Lawton et al., <xref ref-type="bibr" rid="B39">2014</xref>), and in operant self learning (Mendoza et al., <xref ref-type="bibr" rid="B48">2014</xref>).</p>
<p>Among the Fox family of transcription factors, the members of the P subfamily are unique in their requirement to bind to another FoxP protein for transcriptional regulation. Both homo- and hetero-dimerization can occur, mediated by two evolutionary conserved protein domains, the zinc-finger and leucine-zipper (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>; Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>; Mozzi et al., <xref ref-type="bibr" rid="B52">2016</xref>). A recent study reported episodic positive selection around the leucine-zipper of <italic>FoxP2</italic> in specific avian lineages with possible consequences for dimerization (Mozzi et al., <xref ref-type="bibr" rid="B52">2016</xref>). Dimerization of FoxP proteins has so far only been assessed by overexpressing the mouse (Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>) and human (Sin et al., <xref ref-type="bibr" rid="B75">2015</xref>) protein versions in cell lines. The relevance of FoxP protein-protein interaction is emphasized by the fact that <italic>FOXP3</italic> mutations in the dimerization domain cause IPEX syndrome (Immune dysregulation, polyendocrinopathy, enteropathy, X-linked human syndrome; Li et al., <xref ref-type="bibr" rid="B42">2007</xref>). Furthermore, a polymicrogyria patient with a mutation in the leucine zipper region of <italic>FOXP2</italic> showed dysregulation of one of its target genes, <italic>SRXP2</italic> (Roll et al., <xref ref-type="bibr" rid="B68">2010</xref>).</p>
<p>Despite the fact that FoxP factors have the capacity to dimerize in cell lines (Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>; Sin et al., <xref ref-type="bibr" rid="B75">2015</xref>), it is not known whether this interaction also takes place in the vertebrate brain. Overlapping expression of two or more FoxP members occur in the brain of various vertebrates (Teramitsu et al., <xref ref-type="bibr" rid="B82">2004</xref>; Takahashi et al., <xref ref-type="bibr" rid="B81">2008</xref>; Rodenas-Cuadrado et al., <xref ref-type="bibr" rid="B67">2014</xref>; Bowers et al., <xref ref-type="bibr" rid="B8">2014</xref>; Whitney et al., <xref ref-type="bibr" rid="B95">2015</xref>) but few studies have analyzed co-expression at single cell resolution (Bowers et al., <xref ref-type="bibr" rid="B8">2014</xref>; Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>; Whitney et al., <xref ref-type="bibr" rid="B95">2015</xref>). In mice, Foxp2 and Foxp4 are co-expressed in spinal cord motor neuroblasts, and the quantity of Foxp4 protein expressed in those neurons is important for their differentiation (Rousso et al., <xref ref-type="bibr" rid="B69">2012</xref>). In the rat the majority of MSNs co-express Foxp1/2 (Bowers et al., <xref ref-type="bibr" rid="B8">2014</xref>). In the zebra finch FoxP1/2/4, are expressed in specific brain regions with different degrees of overlap (Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>). In Area X, FoxP1/2/4 are co-expressed in a large fraction of striatal MSN, but all other combinations of co-expression also exist to different extents in this cell type (Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>). In budgerigar birds FoxP1/2 also co-localize in the majority of striatal MSN (Whitney et al., <xref ref-type="bibr" rid="B95">2015</xref>). These findings indicate that interactions among the FoxP proteins are possible but do not show that they actually take place.</p>
<p>The aim of this study was to assess whether FoxP1/2/4 of the zebra finch can dimerize in cell lines and in the brain. Furthermore, we asked whether FoxP1 and FoxP4 are able to bind to regulatory regions of two neurally relevant genes, very low density lipoprotein receptor (<italic>VLDLR</italic>), encoding one of the reelin receptors, and Contactin-associated protein-like 2 (<italic>CNTNAP2</italic>) gene which codes for a neurexin called CASPR2 (Rodenas-Cuadrado et al., <xref ref-type="bibr" rid="B67">2014</xref>). Both proteins were previously recognized to be regulated by FoxP2 (Spiteri et al., <xref ref-type="bibr" rid="B79">2007</xref>; Vernes et al., <xref ref-type="bibr" rid="B92">2007</xref>, <xref ref-type="bibr" rid="B89">2008</xref>; Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). Finally we survey the transcriptional regulation of FoxPs expressed individually or in combination, to explore whether homo-dimers and hetero-dimers fulfill different functions. Our results provide the first evidence for molecular interactions of FoxP subfamily members in the brain. We also show that different combinations of FoxP proteins regulate target genes differentially. These findings underscore the need to take these interactions into account in future studies that address why FOXP1 and FOXP2 mutations are associated with the development of impaired speech and other diseases.</p>
</sec>
<sec id="s2" sec-type="materials and methods">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Subjects</title>
<p>Male zebra finches (<italic>Taeniopygia guttata</italic>) were bred in our colony at the Freie Universität Berlin. All procedures were performed according to the guidelines of the governmental law (TierSchG), under permits granted by the local Berlin authorities governing research involving animals. All birds were sacrificed with an Isoflurane overdose.</p>
</sec>
<sec id="s2-2">
<title>Co-Immunoprecipitation (Co-IP)</title>
<p>Co-Immunoprecipitation (Co-IP) was done using Dynabeads® Protein G (Invitrogen, Cat.No.100.04D) following the manufacturer’s protocol with a few changes as follows. We first incubated the antibody-Dynabeads mixture for 15 min at room temperature (for antibody concentrations refer to Table <xref ref-type="table" rid="T1">1</xref>). We subsequently incubated the protein extracts plus antibody-coated Dynabeads mixture for 30 min at 4°C with rotation. We eluted with 20 μl of elution buffer (50 mM Glycin pH 2.8) and before a second round of immunoprecipitation, we neutralized the elution buffer by adding 4.8 μl 1 M TrisHCl pH 7.5 and then added washing buffer to bring the volume to a total of 200 μl. After elution we added 15 μl of 2× Laemmli and prepared lysates for denaturing conditions.</p>
<table-wrap id="T1" position="float">
<label>Table 1</label>
<caption>
<p><bold>Antibodies</bold>.</p>
</caption>
<table frame="hsides" rules="groups">
<thead>
<tr>
<th align="left" colspan="1" rowspan="1">Antigen</th>
<th align="left" colspan="1" rowspan="1">Immunogen</th>
<th align="left" colspan="1" rowspan="1">Manufacturer, species raised in, mono/polyclonal, Cat. no.</th>
<th align="left" colspan="1" rowspan="1">Dilutions</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">Beta-actin</td>
<td align="left" colspan="1" rowspan="1">A slightly modified synthetic b-cytoplasmic actin N-terminal peptide DDDIAALVIDNGSGK conjugated to KLH</td>
<td align="left" colspan="1" rowspan="1">Sigma, mouse monoclonal, A5441</td>
<td align="left" colspan="1" rowspan="1">1:250000-500000 Western blot</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FLAG-M2</td>
<td align="left" colspan="1" rowspan="1">DYKDDDDK FLAG epitope</td>
<td align="left" colspan="1" rowspan="1">Stratagene (Agilent), mouse monoclonal, 200471</td>
<td align="left" colspan="1" rowspan="1">1:2000-10000 Western blot/8 μg CoIP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">Myc</td>
<td align="left" colspan="1" rowspan="1">EQKLISEEDL tag human c-Myc, AA 410-419</td>
<td align="left" colspan="1" rowspan="1">Roth, rabbit polyclonal, 4667.1</td>
<td align="left" colspan="1" rowspan="1">1:2000-10000 Western blot/8 μg CoIP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">V5</td>
<td align="left" colspan="1" rowspan="1">GKPIPNPLLGLDST</td>
<td align="left" colspan="1" rowspan="1">Life Technologies, mouse monoclonal, R960-25</td>
<td align="left" colspan="1" rowspan="1">1:2000-10000 Western blot</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FoxP1</td>
<td align="left" colspan="1" rowspan="1">Full length native protein, purified from mouse FOXP1</td>
<td align="left" colspan="1" rowspan="1">Abcam, mouse monoclonal, ab32010</td>
<td align="left" colspan="1" rowspan="1">1:2000-5000 Western blot/8 μg CoIP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FoxP2</td>
<td align="left" colspan="1" rowspan="1">Synthetic peptide (C) REIEEEPLSEDLE corresponding to amino acids 703-715 of the C-terminus of human FOXP2</td>
<td align="left" colspan="1" rowspan="1">Abcam, rabbit polyclonal, ab16046</td>
<td align="left" colspan="1" rowspan="1">1:2000-5000 Western blot/8 μg Co-IP</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">FoxP4</td>
<td align="left" colspan="1" rowspan="1">The epitope recognized by A302-394A maps to a region between residue 1 and 50 of human forkheadbox P4 using the numbering given in entry NP_001012426.1.</td>
<td align="left" colspan="1" rowspan="1">Bethyl, rabbit polyclonal, A302-394A</td>
<td align="left" colspan="1" rowspan="1">1:2000-5000 Western blot/8 μg Co-IP</td>
</tr>
</tbody>
</table>
</table-wrap>
</sec>
<sec id="s2-3">
<title>Western Blots and Detection</title>
<p>Transfected HeK293 cells were treated with M-PER (Thermo Scientific, Prod#78505) lysis medium for 15 min on ice. Extracts were centrifuged for 10 min at 1500 g and supernatant was stored at −80°C until used. Cell extracts and co-IP’ed proteins were separated by SDS PAGE (8%–10%), transferred to a polyvinylidene fluoride membrane (Roche, Indianapolis, IN, USA), and blocked with Roti-Immunoblock for 2 h or overnight at 4°C. The membranes were then incubated with the desired antibody (Table <xref ref-type="table" rid="T1">1</xref>) overnight at 4°C. Membranes were subsequently washed 3× PBS/0.1% Tween 20 followed by incubation with an HRP-conjugated antibody raised in the appropriate animal (1:2000 dilution; Amersham Biosciences) for another 30 min. Binding was detected on X-ray films using an ECL detection system for HRP (Perkin-Elmer, Boston, MA, USA). Films were developed in a Curix 60 developing machine (Agfa, Cologne, Germany). After the first detection membranes were washed in PBS/0.1% Tween for 5 min, then washed in 0.5 NaOH for 10 min, washed again in PBS/0.1% Tween for 5 min and blocked again and detected with a second/third primary antibody as described before.</p>
</sec>
<sec id="s2-4">
<title>Brain Dissection and Microbiopsies</title>
<p>After sacrificing the bird, the forebrain was quickly dissected, the hemispheres separated, embedded in TissueTec and frozen on dry ice. Hemispheres were stored at −80°C until further processing. Area X microbiopsies were punched as described previously (Olias et al., <xref ref-type="bibr" rid="B57">2014</xref>; Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). Protein was extracted from pooled microbiopsies of the same animal after we had confirmed correct targeting of the desired brain region (Olias et al., <xref ref-type="bibr" rid="B57">2014</xref>; Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>).</p>
</sec>
<sec id="s2-5">
<title>Luciferase Promoter Reporter Assay</title>
<p>For SV40 we seeded ~30000 HeLa cells in 200 μl DMEM medium (GIBCO) containing Penicillin-Streptomycin (Lonza-DE17–602E, 10 UI/ml) per well of a 96-well white flat bottom plate (Nunclon, Cat.No.136101, Denmark). Transfection was performed using Lipofectamine™ 2000 (Invitrogen) following manufacturer’s protocol. Briefly, after seeding plates were incubated for 24 h at 37°C at 5% CO<sub>2</sub>. For transfection, the medium was exchanged with 100 μl of antibiotic free medium before adding the 50 μl transfection mix in each well. Transfection mix consisted of two parts: (a) 25 μl of OptiMEM (GIBCO) containing 30 ng of pGL4.13 (Luciferase gene driven by the SV40 promoter which is known to be regulated by FoxP subfamily members) and 30 ng of pGL4.75 (Renilla gene driven by the CMV promoter that is not affected by FoxP subfamily members, used for normalization of expression changes) and 250 ng total vector over-expressing the different FoxPs for each well; and (b) 1 μl of Lipofectamine™ 2000 (Invitrogen) in 25 μl OptiMEM that was premixed for 5 min at RT. After combining (a) and (b) the mix was incubated for 20 min at RT, then it was added to the cells. After 4–6 h of incubation we changed the medium to 75 μl of antibiotic containing medium and incubated for further 48 h at 37°C in a CO<sub>2</sub> incubator.</p>
<p>For <italic>VLDLR</italic> and <italic>CNTNAP2</italic> we used HeK293 cells, and luciferase assays were done as described previously (Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). Depending on the promoter, we performed between 4 and 7 luciferase assays, each after an independent transfection. Within each assay we used triplicates, e.g., three wells containing the same transfection reagents and quantity of cells. The mean of the triplicate was used for statistical analysis. Each plate was measured once in the ELISA reader.</p>
<p>We measured luminescence using the Dual Glo Luciferase Kit (Promega) following manufacturer’s protocol in an Elisa plate reader (Tecan, GENios; Switzerland). Mean background from untransfected wells was subtracted from all other wells. We present Luciferase results as mean Relative Light Units (Luciferase RLU/Renilla RLU) calculated from the normalized values of 4–7 independent assays.</p>
</sec>
<sec id="s2-6">
<title>Cloning of VLDLR and CNTNAP2 Promoters</title>
<p>The pGL4-VLDLR promoter was cloned as described (Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). The CNTNAP2 promoter was cloned using DNA obtained from a blood sample of an adult bird as the template and amplified with the forward primer 5′-TTGCCTCATTGATTGCAGAA-3′ and reverse primer 5′-CCTGCTTTTCTCCACTTTGG-3′ using High Fidelity Taq (Fermentas K0191). The resulting PCR product was examined on an agarose gel, cleaned from nucleotides with the Nucleo Spin Gel and PCR Clean-up (Macherey-Nagel, Germany, Ref 740609.250), and cloned into the pCR4Blunt-TOPO vector of the Zero blunt PCR cloning kit (Invitrogen) according to the manufacturer’s protocol. Inserts from three independent CNTNAP2 clones were fully sequenced to confirm the sequence of the promoter region of CNTNAP2. Zebra finch CNTNAP2 sequences were deposited to GenBank, accession number NCBI KX943238. We then used forward primer 5′-GATGCTAGCTTGCCTCATTGATTGCAGAA-3′ and reverse primer 5′-GATAGGCCTCCTGCTTTTCTCCACTTTGG-3′ and subcloned the PCR product into the NheI and StuI sites of the pGL4.13 vector to generate the pGL4-CNTNAP2 vector used in Luciferase assays.</p>
<p>We identified putative CpG islands in the CNTNAP2 promoter with the CpG plot tool<xref ref-type="fn" rid="fn0002"><sup>2</sup></xref>. We calculated the GC percentage in the GC rich region of the promoter region of CNTNAP2 using the CpG island calculator<xref ref-type="fn" rid="fn0003"><sup>3</sup></xref>.</p>
</sec>
<sec id="s2-7">
<title>Overexpression and Transfection of HeK293 Cells</title>
<p>Overexpression vectors of FoxP1/2/4 tagged with FLAG or V5 were previously generated (Haesler et al., <xref ref-type="bibr" rid="B29">2004</xref>; Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>). For the generation of Myc tagged FoxP2 we used the FoxP2-V5 tagged sequence as a template and used the forward primer 5′-CGCGGATCCGCCACCATGATGCAGGAATCTGCGACAG-3′ and reverse primer 5′-GCGGAATTCCTACAGATCCTCTTCTGAGATGAGTTTTTGTTCTTCCAGATCTTCAGATAAAGGCTC-3′ and cloned it into pcDNA3, 1 + vector (Invitrogen).</p>
</sec>
<sec id="s2-8">
<title>Electrophoretic Mobility Shift Assays (EMSA)</title>
<p>Proteins for electrophoretic mobility shift assays (EMSAs) were purified using the Protino Ni-NTA Agarose (Macherey-Nagel, Germany, 745400.25) according to manufacturer’s protocol. Protein was quantified using BCA1 (Sigma). EMSA assays were carried out as published previously, using the Oligo described for VLDLR (Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). The oligo we used for CNTNAP2 was 5′-TATTAT<bold>TATTTATTTTT</bold>GTACTCTACATTCCTTGT<bold>TATTTGAT</bold>ACT-3′ (in bold presumed FoxP binding sites containing the ATTT core sequence).</p>
</sec>
<sec id="s2-9">
<title>Statistical Analysis</title>
<p>Statistical tests were performed using the data analysis software R (R Core Team, <xref ref-type="bibr" rid="B650">2013</xref>). After testing for normality, differences between Luciferase experiments were calculated with an analysis of variance (ANOVA) and a Tukey’s HSD <italic>post hoc</italic> test for pairwise comparison (R Core Team, <xref ref-type="bibr" rid="B650">2013</xref>). Graphs were prepared with GraphPad Prism 4.0 (GraphPad Software, San Diego, CA, USA). Data are expressed as mean of means ± SEM.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<title>Results</title>
<sec id="s3-1">
<title>FoxP1/2/4 Zebra Finch Proteins Homo- and Hetero-Dimerize in Cell Lines</title>
<p>To determine whether zebra finch FoxP1/2/4 can homo- and hetero-dimerize in cell lines, as described for the mouse FoxPs (Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>) and human FOXPs (Sin et al., <xref ref-type="bibr" rid="B75">2015</xref>), we transiently overexpressed full length constructs of zebra finch FoxPs tagged either with FLAG or V5 in HeK293 cells and performed co-immunoprecipitation assays. In each Co-IP experiment we used four protein lysates; empty vector lysate (control 1), lysate with one of the two proteins to be tested for co-immunoprecipitation (control 2), another lysate with the other protein to be tested (control 3), and the lysate containing both proteins (experimental). Lysates were co-IP’ed with FLAG antibody, and membranes were first detected with V5 antibodies and sub-sequentially detected with FLAG antibodies. FLAG tagged proteins were immunoprecipitated as expected from lysates containing FLAG-tagged proteins whereas this was not the case for cells expressing an empty vector, or from cell lysates containing V5 tagged proteins (Figures <xref ref-type="fig" rid="F1">1A–F</xref>). In all experiments we detected a protein co-immunoprecipitated in lysates co-transfected with two differently tagged FoxPs (Figures <xref ref-type="fig" rid="F1">1A–F</xref>), indicating protein-protein interactions of the co-expressed FoxPs. Lastly, in all cases the supernatant was mostly depleted of the co-IP’ed protein (Figures <xref ref-type="fig" rid="F1">1A–F</xref>). From these results we conclude that zebra finch FoxP1/2/4 homologs are able to form homo- (Figures <xref ref-type="fig" rid="F1">1A–C</xref>) and hetero-dimers (Figures <xref ref-type="fig" rid="F1">1D–F</xref>) in cell lines.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption>
<p><bold>Western blots after co-immunoprecipitations show that all FoxP1/2/4 zebra finch proteins can homodimerize (A–C)</bold> and heterodimerize <bold>(D–F)</bold>
<italic>in vitro</italic>. HeK293 cells were transfected with combinations of expression vectors encoding FoxP1/2/4 proteins that were tagged with FLAG or V5. The FLAG monoclonal antibody was used to immunoprecipitate proteins from cell extracts. Immunoprecipitated proteins were resolved on SDS-polyacrylamide gels, transferred to nitrocellulose and analyzed by sequential immunoblotting with V5 and FLAG antibodies. In all co-immunoprecipitations <bold>(A–F)</bold>, from left to the right, the first lane shows the empty vector (E.V.) as a negative control; lanes 2 and 3 show protein extracts of transfections with only one of the two tagged proteins as further controls; lane 4 shows the protein extract from transfection with both proteins. The upper panels show the V5 detection, and the lower panels the subsequent FLAG detection. For all conditions and detections we show the input proteins, co-immunoprecipitated proteins and the supernatant after co-immunoprecipitation. In all cases, there is a V5 protein co-immunoprecipitated with the FLAG antibody in the lane where both proteins are present and a reduction of the co-immunoprecipitated protein in the supernatant, showing an interaction of both proteins marked with an asterisk (*).</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0001"></graphic>
</fig>
</sec>
<sec id="s3-2">
<title>FoxP1/2/4 Antibodies Are Specific</title>
<p>To examine whether FoxP1/2/4 proteins also interact in neurons of the zebra finch forebrain, we first characterized commercial antibodies against FoxP1/2/4 zebra finch proteins by over-expressing them individually in HeK293 cells and performing Western Blots. Specific antibodies show a band of about 80 kDa molecular weight in each case. Each antibody only recognized one FoxP (Figures <xref ref-type="fig" rid="F2">2A–C</xref>, top panel), and not the other two. The faint bands in the FoxP1 and FoxP2 lanes in panel c do not correspond to cross reactivity of FoxP4 antibody against FoxP1 and FoxP2 protein, which have a slightly different molecular weight, as can be seen in the FLAG tagged versions (middle panel). The subsequent detection with FLAG (and actin antibodies, lower panel) also demonstrates that over-expressed proteins were present in the protein lysate in similar quantity (Figures <xref ref-type="fig" rid="F2">2A–C</xref>). From these results we conclude that antibodies are specific for the different zebra finch FoxPs.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption>
<p><bold>Western blots demonstrating the specificity of the different FoxP antibodies by detecting only one FoxP protein in extracts of HeK293 cells transfected with an over-expression vector carrying either empty vector (E.V.), or the three FLAG-tagged FoxP proteins</bold>. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and first detected (top panels) with anti-FoxP1 <bold>(A)</bold>, or anti-FoxP2 <bold>(B)</bold>, or anti FoxP4 <bold>(C)</bold> and sequentially detected FLAG/b-actin antibodies as loading controls (middle panels) <bold>(A–C)</bold>. Bottom panels show detection of actin in the samples as a loading control. In all cases, the specificity of the antibody is evident from a single band in the expected lane (*).</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0002"></graphic>
</fig>
</sec>
<sec id="s3-3">
<title>FoxP1/2/4 Zebra Finch Protein Hetero-Dimerize in the Brain</title>
<p>We performed co-IP assays on protein lysates of adult male zebra finch forebrain using the specific antibodies described above. FoxP1 monoclonal antibody was not able to pull down the non-denatured, native brain protein (data not shown), and therefore we used FoxP2 and FoxP4 polyclonal antibodies to pull down protein complexes, and all three antibodies for Western blot detection. As a negative control we used IgG antibodies of the same species in which the specific FoxP antibodies were raised. After IP with FoxP2 or FoxP4 antibodies, we detected co-IP’ed FoxP1 (Figures <xref ref-type="fig" rid="F3">3A,B</xref>). After IP with FoxP2 we detected co-IP’ed FoxP4 (Figure <xref ref-type="fig" rid="F3">3C</xref>). In contrast, no protein of the expected size was precipitated with IgG controls (Figures <xref ref-type="fig" rid="F3">3A–C</xref>). From these results we conclude that FoxP1/2/4 form hetero-dimers in forebrain neurons <italic>in vivo</italic>. To our knowledge this is the first report showing that FoxP1/2/4 proteins can form hetero-dimers in the brain.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption>
<p><bold>FoxP1/2/4 can hetero-dimerize in the brain</bold>. The three panels depict representative co-immunoprecipitation experiments from nuclear protein extracts of adult zebra finch brains with anti-FoxP2 <bold>(A,C)</bold>, anti-FoxP4 <bold>(B)</bold>, or nonspecific IgG <bold>(A–C)</bold> under non-denaturing conditions. Proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and analyzed by sequential immunoblotting with anti-FoxP1 (<bold>A</bold>-left and <bold>B</bold>-right, Westerns), or anti-FoxP2 (<bold>A,C</bold> left Westerns), or anti FoxP4 (<bold>B,C</bold> right panels). In all cases, a hetero-dimer was co-immunoprecipitated with the specific antibodies from whole forebrain lysate and no signal of the same size was detected in the IgG control, suggesting an interaction of FoxP proteins.</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0003"></graphic>
</fig>
</sec>
<sec id="s3-4">
<title>FoxP1/2/4 Zebra Finch Proteins form an Oligomer in a Cell Line</title>
<p>Since the majority of FoxP expressing cells in Area X and the surrounding striatum express FoxP1/2/4 (Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>), and since it is known that FOXP3 is able to homo-oligomerize and hetero-associate in cell lines (Li et al., <xref ref-type="bibr" rid="B42">2007</xref>; Song et al., <xref ref-type="bibr" rid="B76">2012</xref>), we wanted to assess whether all three neurally expressed FoxP proteins could bind in a single protein complex. To test this we performed double co-IP from HeK293 cell lysates co-transfected with full length FoxP1-FLAG, FoxP2-Myc and FoxP4-V5 tagged zebra finch proteins (Figure <xref ref-type="fig" rid="F4">4A</xref> schematic). If FoxP1/2/4 were not able to hetero-associate in a complex after double co-IP we should only detect the two proteins that were immunoprecipitated, but if they hetero-associate in a complex we should be able to detect all three FoxPs. We first immunoprecipitated with Myc, to pull down FoxP2 and all proteins bound to it. After the first immunoprecipitation we found that all three proteins had co-IP’ed (Figure <xref ref-type="fig" rid="F4">4B</xref>). The fact that we detected FoxP1-FLAG and FoxP4-V5 after immunoprecipitating the Myc-taggd FoxP2 could be due to pulled down hetero-dimers of FoxP2 with FoxP1 or with FoxP4. Alternatively, FoxP1/2/4 could have been simultaneously pulled down by immunoprecipitating Myc-tagged FoxP2. To assess this, a second, sequential IP with FLAG was carried out to detect FoxP1-FLAG after the first IP. After the second immunoprecipitation we detected not only FoxP1-FLAG but also co-IP’ed FoxP4-V5 (Figure <xref ref-type="fig" rid="F4">4</xref>, upper blot).</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption>
<p><bold>FoxP1/2/4 zebra finch proteins can oligomerize</bold>
<italic>in vitro</italic><bold>. (A)</bold> Schematic representation of possible combinations of dimers (left panel) or a multimer (right panel) of FoxP1/2/4 in IPs. <bold>(B)</bold> Western blots of double-immunoprecipitation of HeK293 cells transfected with combinations of expression vectors encoding FoxP1 FLAG-tagged, FoxP2 Myc-tagged, and FoxP4 V5-tagged proteins, revealing a FoxP1/2/4 multimer. The left panel of the Western blot shows, from left to right, in the first lane the input protein extract after transfection with all three proteins, followed by lane 2 showing the immunoprecipitated FoxP2-Myc (lower panel, asterisk) with the co-immunoprecipitated FoxP1-FLAG and FoxP4-V5 (upper panel, asterisk). Lane 3 shows the absence of immunoprecipitated proteins when using IgG (rabbit), lane 4 shows the subsequent immunoprecipitation of FoxP1-FLAG (upper panel, asterisk) and co-immunprecipitated FoxP4 and FoxP2 (upper and lower panels respectively, asterisks). In the right Western blot the first lane is again the input, followed by the supernatant of the first immunoprecipitation with Myc and IgG rabbit in lanes 2 and 3, and then the supernatant of the subsequent immunoprecipitation with FLAG.</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0004"></graphic>
</fig>
<p>Not all protein was depleted from the first supernatant, one possible explanation being that FoxP1 homodimers and FoxP4 homodimers were not precipitated by Myc antibodies detecting FoxP2-Myc. Leftover FoxP2 in the supernatant additionally indicates that not all FoxP2 was precipitated by the Myc antibody, likely because of insufficient antibody concentration to deplete all FoxP2 protein and its associated interaction partners. No protein was detected after the second immunoprecipitation in the second supernatant (Figure <xref ref-type="fig" rid="F4">4</xref>, S2).</p>
<p>In summary, these data suggest that FoxP1/2/4 can form a complex including all three proteins, a result which has not been reported before. In addition to this hetero-oligomerization, we also found homo- and hetero-dimerization of all FoxPs (Figures <xref ref-type="fig" rid="F1">1</xref>, <xref ref-type="fig" rid="F3">3</xref>).</p>
</sec>
<sec id="s3-5">
<title>FoxP1/2/4 Zebra Finch Proteins Oligomerize <italic>In Vivo</italic></title>
<p>To assess whether FoxP1/2/4 can hetero-oligomerize in the zebra finch song system we used nuclear protein extracts of Area X. Double IP using specific antibodies detected the three proteins in the co-immunoprecipitated fraction suggesting that FoxP1/2/4 can also hetero-associate <italic>in vivo</italic> in Area X (Figure <xref ref-type="fig" rid="F5">5</xref>).</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption>
<p><bold>Hetero-oligomerization of FoxP1/2/4 occurs in the brain, in song nucleus Area X</bold>. Co-immunoprecipitation performed on nuclear protein extracts from microbiopsies of Area X. The protein extract was split into equal amounts. One was immunoprecipitated with FoxP2 antibody and subsequentially with FoxP4 antibody, the other half was immunoprecipitated with rabbit IgG two times sequentially. Immunoprecipitated proteins were resolved on SDS-polyacrylamide gels, transferred to nitrocellulose, and analyzed by sequential immunoblotting with FoxP2 and FoxP4 or FoxP1 antibodies.</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0005"></graphic>
</fig>
</sec>
<sec id="s3-6">
<title>FoxP1/2/4 Zebra Finch Proteins Repress the SV40 Promoter in Luciferase Promoter Reporter Assays</title>
<p>We assessed whether the homotypic and heterotypic interaction of zebra finch FoxP proteins lead to differential regulatory activity. To do so we used the SV40 promoter driving Luciferase (<italic>Photinus pyralis</italic> synthetic protein). The SV40 promoter has a putative core consensus sequence for binding (T<bold>ATTT</bold>RT) human and murine Foxp1/2/4 (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>; Vernes et al., <xref ref-type="bibr" rid="B90">2006</xref>). For the human and mouse proteins it was shown in luciferase promoter reporter assays that each FoxP can repress the SV40 promoter individually (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>; Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>; Vernes et al., <xref ref-type="bibr" rid="B90">2006</xref>). Likewise, we found that zebra finch FoxP proteins when expressed individually in HeLa cells significantly repressed the transcriptional activity under the control of the SV40 promoter (Figure <xref ref-type="fig" rid="F6">6</xref>; One way ANOVA; <italic>F</italic> = 28.79; DF = 7; <italic>n</italic> = 8; <italic>p</italic> &lt; 0.0001; Tukey’s Multiple comparison Test; compared to empty vector: FoxP1 <italic>p</italic> &lt; 0.0001, FoxP2 <italic>p</italic> = 0.013, and FoxP4 <italic>p</italic> &lt; 0.0001), in the same range as reported for mice and human FOXP1/2/4. Also, like its mammalian homologs, zebra finch FoxP4 repressed transcription stronger than FoxP1 or FoxP2 did, and FoxP2 was a weak repressor of the SV40 promoter (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>; Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>; Vernes et al., <xref ref-type="bibr" rid="B90">2006</xref>). Cells expressing combinations of the different FoxP subfamily members also showed a significant repression of the SV40 promoter (compared to empty vector: FoxP1/2 <italic>p</italic> &lt; 0.0001; FoxP1/4 <italic>p</italic> &lt; 0.0001; FoxP2/4 <italic>p</italic> &lt; 0.0001 and FoxP1/2/4 <italic>p</italic> = 0.0001). There were no significant differences between cells expressing FoxP1 or FoxP4 alone or in any of the combinations tested. We did observe a stronger transcriptional repression in cells expressing FoxP2 in combination with another FoxP subfamily member than when FoxP2 was expressed alone (compared to FoxP2 alone: FoxP1/2 <italic>p</italic> = 0.016; FoxP2/4 <italic>p</italic> = 0.0005 and FoxP1/2/4 <italic>p</italic> &lt; 0.0001). However, we cannot rule out the formation and action of homodimers of FoxPs in those cells. Taken together, FoxP target genes in cells that express only FoxP2 may be less strongly regulated than those that are co-expressed with FoxP1 and/or FoxP4.</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption>
<p><bold>Luciferase assays demonstrate transactivation properties of different combinations of FoxP1/2/4 proteins on the SV40 promoter</bold>. FoxP1/2/4 as well as their combinations significantly repressed the pGL4.13-promoter transcriptional activity through a specific DNA-binding site in the SV40 promoter. Significance levels from all combinations to the empty vector control are represented by stars, **<italic>p</italic> &lt; 0.001–0.01; ***<italic>p</italic> &lt; 0.001. One way ANOVA; <italic>F</italic> = 28.79; DF = 7; <italic>n</italic> = 8; followed by Tukey’s multiple comparison test; Bars show mean of means ± SEM of five independent transfections for each of the eight conditions, presented as luciferase/renilla ratio (RLU), corrected for transfection by pGL4.75 Renilla luciferase activity. 1x = 125 ng of overexpressing vector per well, 2x = 250 ng of overexpressing vector per well. The control transfection value was obtained with the empty expression vector (pcDNA3.1).</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0006"></graphic>
</fig>
</sec>
<sec id="s3-7">
<title><italic>VLDLR</italic> Is a Direct Target Not Only of FoxP2 but Also of FoxP1/4</title>
<p>To explore whether FoxP proteins not only regulate SV40 but also neurally relevant promoters we chose <italic>VLDLR</italic> for a number of reasons: (a) it is a direct target of FoxP2 in humans, mice, and zebra finches (Spiteri et al., <xref ref-type="bibr" rid="B79">2007</xref>; Vernes et al., <xref ref-type="bibr" rid="B92">2007</xref>; Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>); (b) both FoxP2 and VLDLR promote dendrite and dendritic spine development in various species (Niu et al., <xref ref-type="bibr" rid="B55">2004</xref>, <xref ref-type="bibr" rid="B56">2008</xref>; Schulz et al., <xref ref-type="bibr" rid="B71">2010</xref>; Vernes et al., <xref ref-type="bibr" rid="B91">2011</xref>); and (c) in songbirds, FoxP2 and VLDLR are expressed in Area X and the basal ganglia (Balthazart et al., <xref ref-type="bibr" rid="B3">2008</xref>; Hilliard et al., <xref ref-type="bibr" rid="B33">2012</xref>) and are co-regulated in different contexts (singing, age and by molecular manipulations; Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). Most of the work on target genes in the FoxP subfamily that are expressed in the brain have focused on FoxP2, and it is not known how much overlap there is in the binding sites for FoxP1 and FoxP4 and whether they can bind to the same promoter motives. To investigate this we used the <italic>VLDLR</italic>-oligonucleotide that FoxP2 can bind to in EMSA (Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>) and tested whether FoxP1/4 also binds to this probe. The protein extract of HeK293 cells transfected with empty vector (mock extract) presented a non specific shift (n.s.; Figures <xref ref-type="fig" rid="F7">7A,B</xref>, first lane). In the presence of FoxP1 or FoxP4 a specific shift of the DNA was observed, indicating that both proteins are able to bind to the <italic>VLDLR</italic> oligonucleotide (Figure <xref ref-type="fig" rid="F7">7A,B</xref>, second lane). Addition of a specific competitor diminished the intensity of this band (Figure <xref ref-type="fig" rid="F7">7A,B</xref>, third lane). Adding a V5 antibody to the FoxP/oligonucleotide mix resulted in a further shift, strengthening the notion that that FoxP1 or FoxP4 generated the shift (Figure <xref ref-type="fig" rid="F7">7A,B</xref>, fourth lane). From these results we conclude that FoxP1 and FoxP4 can bind to the same <italic>VLDLR</italic> region that FoxP2 binds to, suggesting that all three FoxPs share a common target gene.</p>
<fig id="F7" position="float">
<label>Figure 7</label>
<caption>
<p><bold>FoxP1/2/4 bind and activate the very low density lipoprotein receptor</bold>
<italic>(VLDLR)</italic><bold> promoter</bold>. DNA binding assays with FoxP1 <bold>(A)</bold> and FoxP4 <bold>(B)</bold>. Nuclear extracts (1 μg) from HeK293 cells were incubated with the digoxigenin labeled probe (0.8 ng) representing the 27-bp of the <italic>VLDLR</italic> FoxP2 binding site. Shown in each case are protein lysate of HeK293 cells transiently transfected with empty vector and labeled probe (lane 1), shift in the presence of nuclear extract of FoxPs (lane 2), and complex formation in the presence of 200-fold molar excess of specific un-labeled probe (lane 3) and supershift in the presence of labeled probe, FoxPs protein extract and monoclonal V5 antibody (1 mg/ml; lane 4). In all cases arrows point to free oligo, non specific shift (n.s.), FoxP shift and supershift. <bold>(C)</bold> Luciferase assays were carried out in HeK293 cells to measure effects of a FoxP1/2/4 alone or in combinations on the <italic>VLDLR</italic> promoter. Significance levels from all combinations to the empty vector control are represented by asterisk, **<italic>p</italic> &lt; 0.001–0.01; ***<italic>p</italic> &lt; 0.001. One way analysis of variance (ANOVA); <italic>F</italic> = 26.09; DF = 7 and <italic>n</italic> = 8; followed by Tukey’s multiple comparison. Bars show mean of means ± SEM of four independent transfections, presented as luciferase/renilla ratio (RLU), corrected for transfection by pGL4.75 Renilla luciferase activity. 1x = 125 ng of overexpressing vector per well, 2x = 250 ng of overexpressing vector per well. The control transfection value was obtained with the empty expression vector (pcDNA3.1).</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0007"></graphic>
</fig>
</sec>
<sec id="s3-8">
<title>FoxP1/2/4 Differentially Activate the <italic>VLDLR</italic> Promoter in Luciferase Promoter Reporter Assays</title>
<p>To test whether binding of FoxP1/2/4 to the <italic>VLDLR</italic> promoter leads to an alteration of transcription, we performed luciferase assays using the pGL4-VLDLR vector described previously (Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). There were significant differences in activation of the <italic>VLDLR</italic> promoter depending on the specific combinations of FoxP proteins (One way ANOVA; <italic>F</italic> = 26.09; DF = 7 and <italic>n</italic> = 8; <italic>p</italic> &lt; 0.0001; Figure <xref ref-type="fig" rid="F7">7C</xref>). Tukey’s Multiple comparison Test revealed that when compared to empty vector, FoxP1 was a significantly better activator of the VLDLR promoter than FoxP2 or FoxP4 (FoxP1 <italic>p</italic> &lt; 0.0001, FoxP2 <italic>p</italic> &lt; 0.007 and FoxP4 <italic>p</italic> = 0.0024). However, FoxP2 and FoxP4 were less effective and not significantly different from each other in their ability to activate the VLDLR promoter (<italic>p</italic> = 0.999). Combinations of FoxP1/2/4 did activate the VLDLR promoter to a similar degree (compared to empty vector: FoxP1/2 <italic>p</italic> &lt; 0.0001; FoxP1/4 <italic>p</italic> &lt; 0.0001; FoxP2/4 <italic>p</italic> = 0.0003 and FoxP1/2/4 <italic>p</italic> &lt; 0.0001). Comparing the activation of FoxP2 alone to the FoxP1/2 and FoxP1/2/4 combination (<italic>p</italic> = 0.0078 and <italic>p</italic> = 0.012 respectively) we found a significant difference on the VLDLR promoter but not with the FoxP2/4 combination (<italic>p</italic> = 0.88). There were no differences between the individual activation by FoxP4 and the combinations with FoxP1 (<italic>p</italic> = 0.10) or FoxP2 (<italic>p</italic> = 0.98), but there was a significant difference to the FoxP1/2/4 combination (<italic>p</italic> = 0.034). Taken together FoxP1/2/4 are not only repressors, but are able to bind to the VLDLR promoter and activate it differently depending on the co-expression with other FoxPs.</p>
</sec>
<sec id="s3-9">
<title>Closing the Gap of the <italic>CNTNAP2</italic> Zebra Finch Promoter</title>
<p>To further test the regulatory ability of zebra finch FoxPs on a target gene relevant in Area X, we chose <italic>CNTNAP2</italic> because: (a) <italic>CNTNAP2</italic> is associated with speech disorders, as well as ASD, dyslexia and intellectual disability (Rodenas-Cuadrado et al., <xref ref-type="bibr" rid="B67">2014</xref>) some of which are also associated with FoxP mutations (MacDermot et al., <xref ref-type="bibr" rid="B46">2005</xref>; Vargha-Khadem et al., <xref ref-type="bibr" rid="B87">2005</xref>; Shriberg et al., <xref ref-type="bibr" rid="B72">2006</xref>; Zeesman et al., <xref ref-type="bibr" rid="B96">2006</xref>; Lennon et al., <xref ref-type="bibr" rid="B41">2007</xref>; Pariani et al., <xref ref-type="bibr" rid="B61">2009</xref>; Vernes et al., <xref ref-type="bibr" rid="B88">2009</xref>; Carr et al., <xref ref-type="bibr" rid="B9">2010</xref>; Hamdan et al., <xref ref-type="bibr" rid="B30">2010</xref>; Horn et al., <xref ref-type="bibr" rid="B34">2010</xref>; Bowers and Konopka, <xref ref-type="bibr" rid="B7">2012</xref>; Rice et al., <xref ref-type="bibr" rid="B66">2012</xref>; Žilina et al., <xref ref-type="bibr" rid="B97">2012</xref>; Chien et al., <xref ref-type="bibr" rid="B15">2013</xref>; Le Fevre et al., <xref ref-type="bibr" rid="B40">2013</xref>; Palumbo et al., <xref ref-type="bibr" rid="B59">2013</xref>; Toma et al., <xref ref-type="bibr" rid="B86">2013</xref>); (b) <italic>CNTNAP2</italic> is a direct target of Foxp2 in mice and of FOXP1 in humans (Vernes et al., <xref ref-type="bibr" rid="B92">2007</xref>; O’Roak et al., <xref ref-type="bibr" rid="B58">2011</xref>); (c) FoxP1/2/4 and CNTNAP2 are expressed in Area X and the basal ganglia in zebra finches (Haesler et al., <xref ref-type="bibr" rid="B29">2004</xref>; Panaitof et al., <xref ref-type="bibr" rid="B60">2010</xref>; Condro and White, <xref ref-type="bibr" rid="B17">2014</xref>; Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>); and (d) FoxP2 binds to the <italic>CNTNAP2</italic> promoter region in zebra finches and the expression of both is correlated in adult undirected singing and in non-singing juveniles as well as after FoxP2 lentiviral knockdown (Adam et al., in review; personal communication).</p>
<p>The assembled genome region of the zebra finch <italic>CNTNAP2</italic> promoter contained a sequence gap located ~0.75 kb upstream of the start codon of the first exon of <italic>CNTNAP2</italic> (Figure <xref ref-type="fig" rid="F8">8A</xref>). We cloned and sequenced across the gap, identifying a 462bp fragment, which had a high GC-content of up to 79.50% and was within the CpG island. The CpG island was located ~0.83–1.2 kb upstream of the star codon of the first exon. A TATA box was identified ~20 bp of the transcription start site (TSS). This region had 11 FoxP2 binding sites (Figure <xref ref-type="fig" rid="F8">8A</xref>, red shapes; Pierrou et al., <xref ref-type="bibr" rid="B65">1994</xref>; Stroud et al., <xref ref-type="bibr" rid="B80">2006</xref>; Nelson et al., <xref ref-type="bibr" rid="B54">2013</xref>), four located in the promoter region and 7 in the 5′ UTR region. We were able to close the gap in the genome enabling us to further investigate the previously incomplete <italic>CNTNAP2</italic> promoter sequence and use it for luciferase assays.</p>
<fig id="F8" position="float">
<label>Figure 8</label>
<caption>
<p><bold>FoxP1 activated, FoxP2 repressed and FoxP4 did not bind or regulate the Contactin-associated protein-like 2 (</bold><italic>CNTNAP2</italic><bold>) promoter. (A)</bold> Schematic of the <italic>CNTNAP2</italic> promoter region. Arrows show the region of the primers used to clone the <italic>CNTNAP2</italic> promoter region. The location of the predicted transcription start site (TSS), TATA-box, CpG island (blue box), GAP (white box), 5′ UTR (gray box), coding sequence (CDS, black box) and FOXP2 binding sites (red shapes) are denoted by lines. The fragment used for the EMSA experiments (described in Adam et al., in review) is illustrated by the vertical line labeled “EMSA oligo” on the 5′ UTR region. DNA binding assays with FoxP1 <bold>(B)</bold>, FoxP2 <bold>(C)</bold> and FoxP4 <bold>(D)</bold> with the <italic>CNTNAP2</italic> oligo. Nuclear extracts (1 μg) from HeK293 cells were incubated with the digoxigenin labeled probe (0.8 ng) representing the 46-bp of the <italic>CNTNAP2</italic> FoxP2 binding site. Shown in each case are protein lysate of HeK293 cells transiently transfected with empty vector and labeled probe (lane 1), shift in the presence of nuclear extract of FoxPs (lane 2), and complex formation in the presence of 200-fold molar excess of specific un-labeled probe (lane 3) and supershift in the presence of labeled probe, FoxPs protein extract and monoclonal V5 antibody (1 mg/ml; lane 4). In all cases arrows point at free oligo, non specific shift (n.s.), FoxP shift and supershift. <bold>(E)</bold> Luciferase assays were carried out in HeK293 cells to measure effects of FoxP1/2/4 alone or in combinations on the <italic>CNTNAP2</italic> promoter. Significance levels from all combinations to the empty vector control are represented by asterisks, **<italic>p</italic> &lt; 0.001–0.01; ***<italic>p</italic> &lt; 0.001. One way ANOVA; <italic>F</italic> = 21.66; DF = 7 and <italic>n</italic> = 8; followed by a Tukey’s multiple comparison test. FoxP1 and FoxP2 single transfections significantly activated or repressed the pGL4-CNTNAP2 transcriptional activity through a specific DNA-binding site in the CNTNAP2 promoter (One way ANOVA; Tukey’s multiple comparison test; **<italic>P</italic> &lt; 0.005; ***<italic>P</italic> &lt; 0.0001). FoxP4 as well as all other combinations did not regulate the CNTNAP2 promoter. Bars show mean of means ± SEM of seven independent transfections presented as luciferase/renilla ratio (RLU), corrected for transfection by pGL4.75 Renilla luciferase activity. 1× = 125 ng of overexpressing vector pro well, 2× = 250 ng of overexpressing vector per well. The control transfection value was obtained with the empty expression vector (pcDNA3.1).</p>
</caption>
<graphic xlink:href="fnmol-10-00112-g0008"></graphic>
</fig>
</sec>
<sec id="s3-10">
<title>EMSA Reveals that FoxP1/2 Bind to the <italic>CNTNAP2</italic> Promoter but FoxP4 Does Not</title>
<p>We used an oligonucleotide probe from a sequence in the 5′ UTR region of the zebra finch <italic>CNTNAP2</italic> (Figure <xref ref-type="fig" rid="F8">8A</xref>) to test whether FoxP1/2/4 bind to it. This oligomer was identified in a parallel study on FoxP2 and <italic>CNTNAP2</italic> interactions interactions (Adam et al., in review). FoxP1 was able to bind to the <italic>CNTNAP2</italic> oligo and resulted in two shifted bands, consistent with the possibility that it binds in two of the three FoxP2 binding sites (Pierrou et al., <xref ref-type="bibr" rid="B65">1994</xref>; Enard et al., <xref ref-type="bibr" rid="B22">2009</xref>; Nelson et al., <xref ref-type="bibr" rid="B54">2013</xref>) contained in the oligo (Figure <xref ref-type="fig" rid="F8">8B</xref>, “Materials and Methods” Section). We also confirmed the results of Adam et al. (in review), showing that FoxP2 also binds (Figure <xref ref-type="fig" rid="F8">8C</xref>). Interestingly, FoxP4 did not result in a DNA shift in the EMSA (Figure <xref ref-type="fig" rid="F8">8D</xref>).</p>
</sec>
<sec id="s3-11">
<title>FoxP1 Activates, FoxP2 Represses and FoxP4 Does Not Regulate the <italic>CNTNAP2</italic> Promoter in Luciferase Promoter Reporter Assays</title>
<p>To investigate whether binding of FoxP1 and FoxP2 to the <italic>CNTNAP2</italic> promoter leads to an alteration of transcription, we performed luciferase assays using the pGL4-<italic>CNTNAP2</italic> vector (Figure <xref ref-type="fig" rid="F8">8E</xref>). When tested individually, FoxP1 activated the <italic>CNTNAP2</italic> promoter and FoxP2 repressed it. As expected from the lack of binding ability of FoxP4 to the CNTNAP2 promoter oligo (Figure <xref ref-type="fig" rid="F8">8D</xref>) FoxP4 failed to regulate the <italic>CNTNAP2</italic> promoter in the Luciferase assay (Figure <xref ref-type="fig" rid="F8">8E</xref>; One way ANOVA; <italic>F</italic> = 21.66; DF = 7 and <italic>n</italic> = 8; <italic>p</italic> &lt; 0.0001; Tukey’s Multiple comparison Test; compared to empty vector: FoxP1 <italic>p</italic> = 0.005, FoxP2 <italic>p</italic> &lt; 0.0001 and FoxP4 <italic>p</italic> = 0.91). Moreover, in combination, the different FoxPs also failed to regulate expression driven by the <italic>CNTNAP2</italic> promoter, (compared to empty vector: FoxP1/2 <italic>p</italic> = 0.26; FoxP1/4 <italic>p</italic> = 0.28; FoxP2/4 <italic>p</italic> = 1 and FoxP1/2/4 <italic>p</italic> = 0.22). Interestingly, combinations of FoxP4 with either FoxP1 or FoxP2 did not result in repression or activation, in contrast to FoxP1 or FoxP2 alone, suggesting that hetero-dimerization might affect the regulation of FoxPs. Taken together we show that FoxP1 and FoxP2 can bind to and regulate the <italic>CNTNAP2</italic> promoter, with opposing activities. <italic>CNTNAP2</italic> is an example of how FoxPs may tune the regulation of different targets genes via homo- and hetero-dimerization.</p>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<title>Discussion</title>
<p>The present study demonstrates for the first time that FoxP proteins can not only dimerize in cell lines, as previously shown for mice (Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>) and humans (Sin et al., <xref ref-type="bibr" rid="B75">2015</xref>), but also in the brain. Moreover, we discovered that FoxP proteins can also oligomerize, in cell lines and in the brain, also a novel finding. Specifically, we show that FoxP1/2/4 proteins can associate with each other in Area X, a song nucleus relevant for vocal learning, whose function depends on adequate FoxP2 protein amounts (Miller et al., <xref ref-type="bibr" rid="B50">2008</xref>; Thompson et al., <xref ref-type="bibr" rid="B85">2013</xref>). In addition, we compared the potential of the neurally expressed FoxP proteins to bind to the regulatory regions of <italic>SV40</italic>, <italic>VLDLR</italic> and <italic>CNTNAP2</italic> and regulate their transcriptional activity. Zebra finch FoxP1/2/4 repressed the <italic>SV40</italic> promoter activity, as reported for mouse and human (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>; Vernes et al., <xref ref-type="bibr" rid="B90">2006</xref>). In contrast, FoxP1/2/4 all activated the <italic>VLDLR</italic> promoter. Interestingly, the <italic>CNTNAP2</italic> promoter was regulated differentially; whereas FoxP1 activated it, FoxP2 repressed it and FoxP4 neither bound nor regulated this promoter. Together, these results emphasize the functional importance of the protein-protein interactions among the FoxP subfamily members in regulating their target genes. Since we previously showed that FoxP1/2/4 are expressed in different combinations in the MSN of the basal ganglia, including Area X (Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>), the present findings provide important steps toward understanding how the combinatorial regulation of FoxP2 with its interaction partners may regulate neural function in a circuit relevant for vocal production learning, such as speech in humans and song in birds.</p>
<p>Our findings that different combinations of FoxP1/2/4 can activate the promoter for the reelin receptor <italic>VLDLR</italic> with different strengths are likely to have consequences for spine formation and synaptic transmission in a neuron-specific way, which would facilitate a fine-tuning of VLDLR regulation in Area X MSNs. This is consistent with data in mice and songbirds (Schulz et al., <xref ref-type="bibr" rid="B71">2010</xref>; DiBattista et al., <xref ref-type="bibr" rid="B20">2015</xref>; Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). In addition, given that the cellular levels of FoxP2 vary notably with age, song stereotypy, and singing (Haesler et al., <xref ref-type="bibr" rid="B29">2004</xref>; Teramitsu and White, <xref ref-type="bibr" rid="B83">2006</xref>; Miller et al., <xref ref-type="bibr" rid="B50">2008</xref>; Thompson et al., <xref ref-type="bibr" rid="B85">2013</xref>) but FoxP1 and FoxP4 do not (Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>) it would be interesting to investigate the consequences of dimerization with FoxP1 and FoxP4 on target gene regulation in the situations when FoxP2 levels vary. In Bengalese finches, <italic>FoxP2</italic> mRNA levels as detected by <italic>in situ</italic> hybridization are also down regulated by singing, but down regulation was not observed for FoxP1 levels (Chen et al., <xref ref-type="bibr" rid="B14">2013</xref>).</p>
<p>The present data on the regulation of <italic>CNTNAP2</italic> by FoxP1/2/4 are interesting in light of the differential activation and repression of target genes by FoxP2 (Vernes et al., <xref ref-type="bibr" rid="B92">2007</xref>). In human SH-SY5Y cells FOXP2 represses <italic>CNTNAP2</italic> (Vernes et al., <xref ref-type="bibr" rid="B89">2008</xref>). In our experiments, HeK293 cells transfected with zebra finch FoxP2 also repressed the <italic>CNTNAP2</italic> promoter activity. In contrast, FoxP1 activated the <italic>CNTNAP2</italic> promoter. FoxP4 did not bind and, as expected, did not regulate the <italic>CNTNAP2</italic> promoter. Of note, when we co-transfected FoxP1/4 or FoxP2/4 there was no significant difference in <italic>CNTNAP2</italic> promoter driven reporter gene activity, suggesting that the presence of FoxP4 prevents regulation by both FoxP1 and FoxP2, even though when present alone, they activate or repress, respectively. This type of differential transcriptional regulation by FOXP proteins has been described for a number of different target genes in Hek293 cells (Sin et al., <xref ref-type="bibr" rid="B75">2015</xref>). In the case where the two components of a dimer have opposing functions when expressed alone, the most parsimonious explanation is that the activation (FoxP1) and the repression (FoxP2) cancel each other out in the reporter assay, but other scenarios are of course possible.</p>
<p>In the brain, CNTNAP2 is also co-expressed in MSN of Area X in zebra finches (Panaitof et al., <xref ref-type="bibr" rid="B60">2010</xref>; Condro and White, <xref ref-type="bibr" rid="B17">2014</xref>). The mRNA amounts of <italic>FoxP2</italic> and <italic>CNTNAP2</italic> in this song nucleus of juvenile male finches and in singing adults are positively correlated. Interestingly, in a zebra finch cell line (Itoh and Arnold, <xref ref-type="bibr" rid="B36">2011</xref>) zebra finch FoxP2 activated the <italic>CNTNAP2</italic> promoter (Adam et al., in review), which is in the opposite direction of the present findings with HeK293 cells. This highlights the plasticity with which FoxP proteins can regulate target genes in different cellular contexts, depending on different binding of co-factors that change the regulation of the same gene (Diamond et al., <xref ref-type="bibr" rid="B19">1990</xref>).</p>
<p>Our data underscore the need to take di- and oligo-merization of the different FoxP proteins more into consideration when trying to understand how mutations of <italic>FOXP1</italic> (Hamdan et al., <xref ref-type="bibr" rid="B30">2010</xref>) and <italic>FOXP2</italic> (Lai et al., <xref ref-type="bibr" rid="B38">2001</xref>) cause disease. Sin et al. (<xref ref-type="bibr" rid="B75">2015</xref>) and the present data show that different FoxP proteins can share the same target gene, but that different combinations of proteins can result in opposite effects. It is therefore easily imaginable that a mutation in FoxP1 or FoxP2 could have different effects on the target genes in different neuron types, depending on which other FoxP proteins are co-expressed in the particular cell type (Haesler et al., <xref ref-type="bibr" rid="B29">2004</xref>; Teramitsu et al., <xref ref-type="bibr" rid="B82">2004</xref>; Bowers et al., <xref ref-type="bibr" rid="B8">2014</xref>; Mendoza et al., <xref ref-type="bibr" rid="B49">2015</xref>). This idea is consistent with data from cell lines showing that the subcellular localization deficits caused by FOXP2 mutations can be rescued by co-expression with the wild-type protein (Mizutani et al., <xref ref-type="bibr" rid="B51">2007</xref>; Vernes et al., <xref ref-type="bibr" rid="B88">2009</xref>). It has not been tested whether co-expression with FOXP1 or FOXP4 would have the same effect. If so, it could explain why some tissues might be much more vulnerable to the effects of mutations than others.</p>
<p>Our data do not address which type of protein-protein interaction the homo-and heterodimerization makes use of. FoxP proteins have (at least) two ways to associate or interact: the leucine zipper motif and domain swapping, e.g., the exchange of identical structural elements involving the Forkhead domain (Stroud et al., <xref ref-type="bibr" rid="B80">2006</xref>; Bandukwala et al., <xref ref-type="bibr" rid="B4">2011</xref>; Chu et al., <xref ref-type="bibr" rid="B16">2011</xref>). FoxP proteins with mutations in the leucine zipper protein domain cannot associate (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>; Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>; Chae et al., <xref ref-type="bibr" rid="B12">2006</xref>), nor bind to DNA or regulate target genes (Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>). For FOXP2 and FOXP3 the inability to dimerize via this domain has also been linked to disorders (Bennett et al., <xref ref-type="bibr" rid="B5">2001</xref>; Li et al., <xref ref-type="bibr" rid="B42">2007</xref>; Roll et al., <xref ref-type="bibr" rid="B68">2010</xref>). Domain swapping has been described for FOXP1/2/3 (Stroud et al., <xref ref-type="bibr" rid="B80">2006</xref>; Bandukwala et al., <xref ref-type="bibr" rid="B4">2011</xref>; Chu et al., <xref ref-type="bibr" rid="B16">2011</xref>) but not so far for FOXP4. It is not known how dimers or multimers of FoxP proteins interact with the regulatory regions of the target genes in any species. In addition, the relative functional importance of associations via the leucine zipper or via domain swapping has not been resolved. One important difference between both types of interaction is that domain swapping has only been reported for FoxP proteins of the same type and not for hetero-associations. In principle, these should also be possible, because all FOXPs share the proline that was reported to be important for domain swapping (Medina et al., <xref ref-type="bibr" rid="B47">2016</xref>) and that other Fox proteins lack. They have an alanine amino acid instead at that position (Stroud et al., <xref ref-type="bibr" rid="B80">2006</xref>; Perumal et al., <xref ref-type="bibr" rid="B62">2015</xref>). In mice the Foxp1/2/4 proteins need to homo- and hetero-dimerize in order to bind DNA and regulate the promoter of the murine CC10 gene, relevant for lung development (Li et al., <xref ref-type="bibr" rid="B43">2004a</xref>). The leucine zipper is a characteristic feature of the FoxP subfamily and is present also in all zebra finch FoxP proteins and episodic positive selection of this domain occurred in some bird species (Mozzi et al., <xref ref-type="bibr" rid="B52">2016</xref>).</p>
<p>Finally, our data are the first to address neural targets regulated by FoxP1 and FoxP4. We tested the binding of two known targets of FoxP2 in zebra finches, <italic>VLDLR</italic> and <italic>CNTNAP2</italic>. All zebra finch FoxP proteins studied bound to the <italic>VLDLR</italic> oligonucleotide, which was previously shown to bind to FoxP2 (Adam et al., <xref ref-type="bibr" rid="B1">2016</xref>). The <italic>VLDLR</italic> oligonucleotide contains a partial FOXP core sequence, <bold>ATTT</bold> (Stroud et al., <xref ref-type="bibr" rid="B80">2006</xref>) and a sequence that resembles the FOXP1 consensus sequence, TT<bold>ATTT</bold>AT (Wang et al., <xref ref-type="bibr" rid="B93">2003</xref>). FOXP2 has similar binding sites (Vernes et al., <xref ref-type="bibr" rid="B89">2008</xref>; Enard et al., <xref ref-type="bibr" rid="B22">2009</xref>; Nelson et al., <xref ref-type="bibr" rid="B54">2013</xref>). All FoxPs share the FOX binding site T<bold>RTTT</bold>AY (Pierrou et al., <xref ref-type="bibr" rid="B65">1994</xref>). The <italic>CNTNAP2</italic> oligonucleotide contains three putative FoxP2 binding sites. One TATTTAT (Enard et al., <xref ref-type="bibr" rid="B22">2009</xref>), and two other sites that have the core ATTT mentioned above Stroud et al. (<xref ref-type="bibr" rid="B80">2006</xref>). It is not clear why FoxP4 of zebra finches is not binding, since it would be expected to bind in the presences of the full FoxP consensus (TATTTAT) binding site. However, the binding of FoxP4 is less studied and target genes are not known. To further validate that these putative binding sites are neurally and biologically relevant ChIP data are needed.</p>
<p>In summary, we show that zebra finch FoxP proteins can interact with each other in all combinations in the songbird brain. We show that all neurally expressed FoxPs have the capacity to bind to and regulate the target genes <italic>VLDLR</italic> and <italic>CNTNAP2</italic>. Importantly, different FoxP combinations resulted in specific, differential transcriptional regulation. Together, our data demonstrate how versatile and variable FoxP regulation can be in the neural context.</p>
</sec>
<sec id="s5">
<title>Author Contributions</title>
<p>EM and CS: experiment design, analysis of data and wrote the manuscript. EM did all experiments.</p>
</sec>
<sec id="s6">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
</body>
<back>
<ack>
<p>CS was supported by Deutsche Forschungsgemeinschaft (DFG, SFB665). EM was supported by Consejo Nacional de Ciencia y Tecnología (CONACYT). We thank Ursula Kobalz and Nshdejan Arpik for invaluable technical help. We thank Anna Günther and Anne Voigt for help with the project.</p>
</ack>
<fn-group>
<fn id="fn0001">
<p><sup>1</sup>Following nomenclature proposed by Kaestner et al. (<xref ref-type="bibr" rid="B37">2000</xref>). <italic>FOXP</italic> refers to the human gene, <italic>Foxp</italic> refers to the mouse gene and <italic>FoxP</italic> refers to all other species.</p>
</fn>
<fn id="fn0002">
<p>
<sup>2</sup>
<ext-link ext-link-type="uri" xlink:href="http://www.ebi.ac.uk/Tools/seqstats/emboss_cpgplot/">http://www.ebi.ac.uk/Tools/seqstats/emboss_cpgplot/</ext-link>
</p>
</fn>
<fn id="fn0003">
<p>
<sup>3</sup>
<ext-link ext-link-type="uri" xlink:href="http://www.bioinformatics.org/sms2/cpg_islands.html">http://www.bioinformatics.org/sms2/cpg_islands.html</ext-link>
</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adam</surname><given-names>I.</given-names></name><name><surname>Mendoza</surname><given-names>E.</given-names></name><name><surname>Kobalz</surname><given-names>U.</given-names></name><name><surname>Wohlgemuth</surname><given-names>S.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name></person-group> (<year>2016</year>). <article-title>FoxP2 directly regulates the reelin receptor <italic>VLDLR</italic> developmentally and by singing</article-title>. <source/>Mol. Cell. Neurosci.
<volume>74</volume>, <fpage>96</fpage>–<lpage>105</lpage>. <pub-id pub-id-type="doi">10.1016/j.mcn.2016.04.002</pub-id><pub-id pub-id-type="pmid">27105823</pub-id></mixed-citation>
</ref>
<ref id="B2">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bacon</surname><given-names>C.</given-names></name><name><surname>Rappold</surname><given-names>G. A.</given-names></name></person-group> (<year>2012</year>). <article-title>The distinct and overlapping phenotypic spectra of <italic>FOXP1</italic> and <italic>FOXP2</italic> in cognitive disorders</article-title>. <source/>Hum. Genet.
<volume>131</volume>, <fpage>1687</fpage>–<lpage>1698</lpage>. <pub-id pub-id-type="doi">10.1007/s00439-012-1193-z</pub-id><pub-id pub-id-type="pmid">22736078</pub-id></mixed-citation>
</ref>
<ref id="B3">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Balthazart</surname><given-names>J.</given-names></name><name><surname>Voigt</surname><given-names>C.</given-names></name><name><surname>Boseret</surname><given-names>G.</given-names></name><name><surname>Ball</surname><given-names>G. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Expression of reelin, its receptors and its intracellular signaling protein, Disabled1 in the canary brain: relationships with the song control system</article-title>. <source/>Neuroscience
<volume>153</volume>, <fpage>944</fpage>–<lpage>962</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuroscience.2008.02.020</pub-id><pub-id pub-id-type="pmid">18448255</pub-id></mixed-citation>
</ref>
<ref id="B4">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bandukwala</surname><given-names>H. S.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Feuerer</surname><given-names>M.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Barboza</surname><given-names>B.</given-names></name><name><surname>Ghosh</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Structure of a domain-swapped FOXP3 dimer on DNA and its function in regulatory T cells</article-title>. <source/>Immunity
<volume>34</volume>, <fpage>479</fpage>–<lpage>491</lpage>. <pub-id pub-id-type="doi">10.1016/j.immuni.2011.02.017</pub-id><pub-id pub-id-type="pmid">21458306</pub-id></mixed-citation>
</ref>
<ref id="B5">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bennett</surname><given-names>C. L.</given-names></name><name><surname>Christie</surname><given-names>J.</given-names></name><name><surname>Ramsdell</surname><given-names>F.</given-names></name><name><surname>Brunkow</surname><given-names>M. E.</given-names></name><name><surname>Ferguson</surname><given-names>P. J.</given-names></name><name><surname>Whitesell</surname><given-names>L.</given-names></name><etal></etal></person-group>. (<year>2001</year>). <article-title>The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3</article-title>. <source/>Nat. Genet.
<volume>27</volume>, <fpage>20</fpage>–<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1038/83713</pub-id><pub-id pub-id-type="pmid">11137993</pub-id></mixed-citation>
</ref>
<ref id="B6">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bolhuis</surname><given-names>J. J.</given-names></name><name><surname>Okanoya</surname><given-names>K.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Twitter evolution: converging mechanisms in birdsong and human speech</article-title>. <source/>Nat. Rev. Neurosci.
<volume>11</volume>, <fpage>747</fpage>–<lpage>759</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2931</pub-id><pub-id pub-id-type="pmid">20959859</pub-id></mixed-citation>
</ref>
<ref id="B7">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>J. M.</given-names></name><name><surname>Konopka</surname><given-names>G.</given-names></name></person-group> (<year>2012</year>). <article-title>The role of the FOXP family of transcription factors in ASD</article-title>. <source/>Dis. Markers
<volume>33</volume>, <fpage>251</fpage>–<lpage>260</lpage>. <pub-id pub-id-type="doi">10.3233/DMA-2012-0919</pub-id><pub-id pub-id-type="pmid">22960337</pub-id></mixed-citation>
</ref>
<ref id="B8">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bowers</surname><given-names>J. M.</given-names></name><name><surname>Perez-Pouchoulen</surname><given-names>M.</given-names></name><name><surname>Roby</surname><given-names>C. R.</given-names></name><name><surname>Ryan</surname><given-names>T. E.</given-names></name><name><surname>McCarthy</surname><given-names>M. M.</given-names></name></person-group> (<year>2014</year>). <article-title>Androgen modulation of Foxp1 and Foxp2 in the developing rat brain: impact on sex specific vocalization</article-title>. <source/>Endocrinology
<volume>155</volume>, <fpage>4881</fpage>–<lpage>4894</lpage>. <pub-id pub-id-type="doi">10.1210/en.2014-1486</pub-id><pub-id pub-id-type="pmid">25247470</pub-id></mixed-citation>
</ref>
<ref id="B9">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Carr</surname><given-names>C. W.</given-names></name><name><surname>Moreno-De-Luca</surname><given-names>D.</given-names></name><name><surname>Parker</surname><given-names>C.</given-names></name><name><surname>Zimmerman</surname><given-names>H. H.</given-names></name><name><surname>Ledbetter</surname><given-names>N.</given-names></name><name><surname>Martin</surname><given-names>C. L.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Chiari I malformation, delayed gross motor skills, severe speech delay, and epileptiform discharges in a child with FOXP1 haploinsufficiency</article-title>. <source/>Eur. J. Hum. Genet.
<volume>18</volume>, <fpage>1216</fpage>–<lpage>1220</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2010.96</pub-id><pub-id pub-id-type="pmid">20571508</pub-id></mixed-citation>
</ref>
<ref id="B10">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Castellucci</surname><given-names>G. A.</given-names></name><name><surname>McGinley</surname><given-names>M. J.</given-names></name><name><surname>McCormick</surname><given-names>D. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Knockout of Foxp2 disrupts vocal development in mice</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>23305</fpage>. <pub-id pub-id-type="doi">10.1038/srep23305</pub-id><pub-id pub-id-type="pmid">26980647</pub-id></mixed-citation>
</ref>
<ref id="B11">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chabout</surname><given-names>J.</given-names></name><name><surname>Sarkar</surname><given-names>A.</given-names></name><name><surname>Patel</surname><given-names>S. R.</given-names></name><name><surname>Radden</surname><given-names>T.</given-names></name><name><surname>Dunson</surname><given-names>D. B.</given-names></name><name><surname>Fisher</surname><given-names>S. E.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>A Foxp2 mutation implicated in human speech deficits alters sequencing of ultrasonic vocalizations in adult male mice</article-title>. <source/>Front. Behav. Neurosci.
<volume>10</volume>:<fpage>197</fpage>. <pub-id pub-id-type="doi">10.3389/fnbeh.2016.00197</pub-id><pub-id pub-id-type="pmid">27812326</pub-id></mixed-citation>
</ref>
<ref id="B12">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chae</surname><given-names>W.-J.</given-names></name><name><surname>Henegariu</surname><given-names>O.</given-names></name><name><surname>Lee</surname><given-names>S.-K.</given-names></name><name><surname>Bothwell</surname><given-names>A. L. M.</given-names></name></person-group> (<year>2006</year>). <article-title>The mutant leucine-zipper domain impairs both dimerization and suppressive function of Foxp3 in T cells</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>103</volume>, <fpage>9631</fpage>–<lpage>9636</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0600225103</pub-id><pub-id pub-id-type="pmid">16769892</pub-id></mixed-citation>
</ref>
<ref id="B13">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Charng</surname><given-names>W.-L.</given-names></name><name><surname>Karaca</surname><given-names>E.</given-names></name><name><surname>Coban Akdemir</surname><given-names>Z.</given-names></name><name><surname>Gambin</surname><given-names>T.</given-names></name><name><surname>Atik</surname><given-names>M. M.</given-names></name><name><surname>Gu</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Exome sequencing in mostly consanguineous Arab families with neurologic disease provides a high potential molecular diagnosis rate</article-title>. <source/>BMC Med. Genomics
<volume>9</volume>:<fpage>42</fpage>. <pub-id pub-id-type="doi">10.1186/s12920-016-0208-3</pub-id><pub-id pub-id-type="pmid">27435318</pub-id></mixed-citation>
</ref>
<ref id="B14">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>Heston</surname><given-names>J. B.</given-names></name><name><surname>Burkett</surname><given-names>Z. D.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2013</year>). <article-title>Expression analysis of the speech-related genes FoxP1 and FoxP2 and their relation to singing behavior in two songbird species</article-title>. <source/>J. Exp. Biol.
<volume>216</volume>, <fpage>3682</fpage>–<lpage>3692</lpage>. <pub-id pub-id-type="doi">10.1242/jeb.085886</pub-id><pub-id pub-id-type="pmid">24006346</pub-id></mixed-citation>
</ref>
<ref id="B15">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chien</surname><given-names>W.-H.</given-names></name><name><surname>Gau</surname><given-names>S. S.-F.</given-names></name><name><surname>Chen</surname><given-names>C.-H.</given-names></name><name><surname>Tsai</surname><given-names>W.-C.</given-names></name><name><surname>Wu</surname><given-names>Y.-Y.</given-names></name><name><surname>Chen</surname><given-names>P.-H.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Increased gene expression of FOXP1 in patients with autism spectrum disorders</article-title>. <source/>Mol. Autism
<volume>4</volume>:<fpage>23</fpage>. <pub-id pub-id-type="doi">10.1186/2040-2392-4-23</pub-id><pub-id pub-id-type="pmid">23815876</pub-id></mixed-citation>
</ref>
<ref id="B16">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chu</surname><given-names>Y.-P.</given-names></name><name><surname>Chang</surname><given-names>C.-H.</given-names></name><name><surname>Shiu</surname><given-names>J.-H.</given-names></name><name><surname>Chang</surname><given-names>Y.-T.</given-names></name><name><surname>Chen</surname><given-names>C.-Y.</given-names></name><name><surname>Chuang</surname><given-names>W.-J.</given-names></name></person-group> (<year>2011</year>). <article-title>Solution structure and backbone dynamics of the DNA-binding domain of FOXP1: insight into its domain swapping and DNA binding</article-title>. <source/>Protein Sci.
<volume>20</volume>, <fpage>908</fpage>–<lpage>924</lpage>. <pub-id pub-id-type="doi">10.1002/pro.626</pub-id><pub-id pub-id-type="pmid">21416545</pub-id></mixed-citation>
</ref>
<ref id="B17">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Condro</surname><given-names>M. C.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2014</year>). <article-title>Distribution of language-related Cntnap2 protein in neural circuits critical for vocal learning</article-title>. <source/>J. Comp. Neurol.
<volume>522</volume>, <fpage>169</fpage>–<lpage>185</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23394</pub-id><pub-id pub-id-type="pmid">23818387</pub-id></mixed-citation>
</ref>
<ref id="B18">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DasGupta</surname><given-names>S.</given-names></name><name><surname>Ferreira</surname><given-names>C. H.</given-names></name><name><surname>Miesenböck</surname><given-names>G.</given-names></name></person-group> (<year>2014</year>). <article-title>FoxP influences the speed and accuracy of a perceptual decision in <italic>Drosophila</italic></article-title>. <source/>Science
<volume>344</volume>, <fpage>901</fpage>–<lpage>904</lpage>. <pub-id pub-id-type="doi">10.1126/science.1252114</pub-id><pub-id pub-id-type="pmid">24855268</pub-id></mixed-citation>
</ref>
<ref id="B19">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Diamond</surname><given-names>M. I.</given-names></name><name><surname>Miner</surname><given-names>J. N.</given-names></name><name><surname>Yoshinaga</surname><given-names>S. K.</given-names></name><name><surname>Yamamoto</surname><given-names>K. R.</given-names></name></person-group> (<year>1990</year>). <article-title>Transcription factor interactions: selectors of positive or negative regulation from a single DNA element</article-title>. <source/>Science
<volume>249</volume>, <fpage>1266</fpage>–<lpage>1272</lpage>. <pub-id pub-id-type="doi">10.1016/0168-9525(90)90267-a</pub-id><pub-id pub-id-type="pmid">2119054</pub-id></mixed-citation>
</ref>
<ref id="B20">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>DiBattista</surname><given-names>A. M.</given-names></name><name><surname>Dumanis</surname><given-names>S. B.</given-names></name><name><surname>Song</surname><given-names>J. M.</given-names></name><name><surname>Bu</surname><given-names>G.</given-names></name><name><surname>Weeber</surname><given-names>E.</given-names></name><name><surname>William Rebeck</surname><given-names>G.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Very low density lipoprotein receptor regulates dendritic spine formation in a RasGRF1/CaMKII dependent manner</article-title>. <source/>Biochim. Biophys. Acta
<volume>1853</volume>, <fpage>904</fpage>–<lpage>917</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbamcr.2015.01.015</pub-id><pub-id pub-id-type="pmid">25644714</pub-id></mixed-citation>
</ref>
<ref id="B21">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Doupe</surname><given-names>A. J.</given-names></name><name><surname>Kuhl</surname><given-names>P. K.</given-names></name></person-group> (<year>1999</year>). <article-title>Birdsong and human speech: common themes and mechanisms</article-title>. <source/>Annu. Rev. Neurosci.
<volume>22</volume>, <fpage>567</fpage>–<lpage>631</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.neuro.22.1.567</pub-id><pub-id pub-id-type="pmid">10202549</pub-id></mixed-citation>
</ref>
<ref id="B22">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Enard</surname><given-names>W.</given-names></name><name><surname>Gehre</surname><given-names>S.</given-names></name><name><surname>Hammerschmidt</surname><given-names>K.</given-names></name><name><surname>Hölter</surname><given-names>S. M.</given-names></name><name><surname>Blass</surname><given-names>T.</given-names></name><name><surname>Somel</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2009</year>). <article-title>A humanized version of Foxp2 affects cortico-basal ganglia circuits in mice</article-title>. <source/>Cell
<volume>137</volume>, <fpage>961</fpage>–<lpage>971</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2009.03.041</pub-id><pub-id pub-id-type="pmid">19490899</pub-id></mixed-citation>
</ref>
<ref id="B23">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ferland</surname><given-names>R. J.</given-names></name><name><surname>Cherry</surname><given-names>T. J.</given-names></name><name><surname>Preware</surname><given-names>P. O.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name><name><surname>Walsh</surname><given-names>C. A.</given-names></name></person-group> (<year>2003</year>). <article-title>Characterization of Foxp2 and Foxp1 mRNA and protein in the developing and mature brain</article-title>. <source/>J. Comp. Neurol.
<volume>460</volume>, <fpage>266</fpage>–<lpage>279</lpage>. <pub-id pub-id-type="doi">10.1002/cne.10654</pub-id><pub-id pub-id-type="pmid">12687690</pub-id></mixed-citation>
</ref>
<ref id="B24">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>French</surname><given-names>C. A.</given-names></name><name><surname>Fisher</surname><given-names>S. E.</given-names></name></person-group> (<year>2014</year>). <article-title>What can mice tell us about Foxp2 function?</article-title>
<source/>Curr. Opin. Neurobiol.
<volume>28C</volume>, <fpage>72</fpage>–<lpage>79</lpage>. <pub-id pub-id-type="doi">10.1016/j.conb.2014.07.003</pub-id><pub-id pub-id-type="pmid">25048596</pub-id></mixed-citation>
</ref>
<ref id="B25">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fröhlich</surname><given-names>H.</given-names></name><name><surname>Rafiullah</surname><given-names>R.</given-names></name><name><surname>Schmitt</surname><given-names>N.</given-names></name><name><surname>Abele</surname><given-names>S.</given-names></name><name><surname>Rappold</surname><given-names>G. A.</given-names></name></person-group> (<year>2017</year>). <article-title>Foxp1 expression is essential for sex-specific murine neonatal ultrasonic vocalization</article-title>. <source/>Hum. Mol. Genet. [Epub ahead of print]. <pub-id pub-id-type="doi">10.1093/hmg/ddx055</pub-id><pub-id pub-id-type="pmid">28204507</pub-id></mixed-citation>
</ref>
<ref id="B26">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Girirajan</surname><given-names>S.</given-names></name><name><surname>Brkanac</surname><given-names>Z.</given-names></name><name><surname>Coe</surname><given-names>B. P.</given-names></name><name><surname>Baker</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Vu</surname><given-names>T. H.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Relative burden of large CNVs on a range of neurodevelopmental phenotypes</article-title>. <source/>PLoS Genet.
<volume>7</volume>:<fpage>e1002334</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002334</pub-id><pub-id pub-id-type="pmid">22102821</pub-id></mixed-citation>
</ref>
<ref id="B27">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Groszer</surname><given-names>M.</given-names></name><name><surname>Keays</surname><given-names>D. A.</given-names></name><name><surname>Deacon</surname><given-names>R. M.</given-names></name><name><surname>de Bono</surname><given-names>J. P.</given-names></name><name><surname>Prasad-Mulcare</surname><given-names>S.</given-names></name><name><surname>Gaub</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Impaired synaptic plasticity and motor learning in mice with a point mutation implicated in human speech deficits</article-title>. <source/>Curr. Biol.
<volume>18</volume>, <fpage>354</fpage>–<lpage>362</lpage>. <pub-id pub-id-type="doi">10.1016/j.cub.2008.01.060</pub-id><pub-id pub-id-type="pmid">18328704</pub-id></mixed-citation>
</ref>
<ref id="B28">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haesler</surname><given-names>S.</given-names></name><name><surname>Rochefort</surname><given-names>C.</given-names></name><name><surname>Georgi</surname><given-names>B.</given-names></name><name><surname>Licznerski</surname><given-names>P.</given-names></name><name><surname>Osten</surname><given-names>P.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name></person-group> (<year>2007</year>). <article-title>Incomplete and inaccurate vocal imitation after knockdown of FoxP2 in songbird basal ganglia nucleus Area X</article-title>. <source/>PLoS Biol.
<volume>5</volume>:<fpage>e321</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pbio.0050321</pub-id><pub-id pub-id-type="pmid">18052609</pub-id></mixed-citation>
</ref>
<ref id="B29">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Haesler</surname><given-names>S.</given-names></name><name><surname>Wada</surname><given-names>K.</given-names></name><name><surname>Nshdejan</surname><given-names>A.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name><name><surname>Lints</surname><given-names>T.</given-names></name><name><surname>Jarvis</surname><given-names>E. D.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>FoxP2 expression in avian vocal learners and non-learners</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>3164</fpage>–<lpage>3175</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.4369-03.2004</pub-id><pub-id pub-id-type="pmid">15056696</pub-id></mixed-citation>
</ref>
<ref id="B30">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>F. F.</given-names></name><name><surname>Daoud</surname><given-names>H.</given-names></name><name><surname>Rochefort</surname><given-names>D.</given-names></name><name><surname>Piton</surname><given-names>A.</given-names></name><name><surname>Gauthier</surname><given-names>J.</given-names></name><name><surname>Langlois</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title><italic>De Novo</italic> mutations in <italic>FOXP1</italic> in cases with intellectual disability, autism, and language impairment</article-title>. <source/>Am. J. Hum. Genet.
<volume>87</volume>, <fpage>671</fpage>–<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1016/j.ajhg.2010.09.017</pub-id><pub-id pub-id-type="pmid">20950788</pub-id></mixed-citation>
</ref>
<ref id="B31">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hannenhalli</surname><given-names>S.</given-names></name><name><surname>Kaestner</surname><given-names>K. H.</given-names></name></person-group> (<year>2009</year>). <article-title>The evolution of Fox genes and their role in development and disease</article-title>. <source/>Nat. Rev. Genet.
<volume>10</volume>, <fpage>233</fpage>–<lpage>240</lpage>. <pub-id pub-id-type="doi">10.1038/nrg2523</pub-id><pub-id pub-id-type="pmid">19274050</pub-id></mixed-citation>
</ref>
<ref id="B32">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heston</surname><given-names>J. B.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Behavior-linked FoxP2 regulation enables zebra finch vocal learning</article-title>. <source/>J. Neurosci.
<volume>35</volume>, <fpage>2885</fpage>–<lpage>2894</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.3715-14.2015</pub-id><pub-id pub-id-type="pmid">25698728</pub-id></mixed-citation>
</ref>
<ref id="B33">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hilliard</surname><given-names>A. T.</given-names></name><name><surname>Miller</surname><given-names>J. E.</given-names></name><name><surname>Fraley</surname><given-names>E. R.</given-names></name><name><surname>Horvath</surname><given-names>S.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2012</year>). <article-title>Molecular microcircuitry underlies functional specification in a Basal Ganglia circuit dedicated to vocal learning</article-title>. <source/>Neuron
<volume>73</volume>, <fpage>537</fpage>–<lpage>552</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.01.005</pub-id><pub-id pub-id-type="pmid">22325205</pub-id></mixed-citation>
</ref>
<ref id="B34">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Horn</surname><given-names>D.</given-names></name><name><surname>Kapeller</surname><given-names>J.</given-names></name><name><surname>Rivera-Brugués</surname><given-names>N.</given-names></name><name><surname>Moog</surname><given-names>U.</given-names></name><name><surname>Lorenz-Depiereux</surname><given-names>B.</given-names></name><name><surname>Eck</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Identification of FOXP1 deletions in three unrelated patients with mental retardation and significant speech and language deficits</article-title>. <source/>Hum. Mutat.
<volume>31</volume>, <fpage>E1851</fpage>–<lpage>E1860</lpage>. <pub-id pub-id-type="doi">10.1002/humu.21362</pub-id><pub-id pub-id-type="pmid">20848658</pub-id></mixed-citation>
</ref>
<ref id="B35">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huehn</surname><given-names>J.</given-names></name><name><surname>Polansky</surname><given-names>J. K.</given-names></name><name><surname>Hamann</surname><given-names>A.</given-names></name></person-group> (<year>2009</year>). <article-title>Epigenetic control of FOXP3 expression: the key to a stable regulatory T-cell lineage?</article-title>
<source/>Nat. Rev. Immunol.
<volume>9</volume>, <fpage>83</fpage>–<lpage>89</lpage>. <pub-id pub-id-type="doi">10.1038/nri2474</pub-id><pub-id pub-id-type="pmid">19114986</pub-id></mixed-citation>
</ref>
<ref id="B36">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>Y.</given-names></name><name><surname>Arnold</surname><given-names>A. P.</given-names></name></person-group> (<year>2011</year>). <article-title>Zebra finch cell lines from naturally occurring tumors</article-title>. <source/>in vitro Cell. Dev. Biol. Anim.
<volume>47</volume>, <fpage>280</fpage>–<lpage>282</lpage>. <pub-id pub-id-type="doi">10.1007/s11626-011-9392-9</pub-id><pub-id pub-id-type="pmid">21359817</pub-id></mixed-citation>
</ref>
<ref id="B37">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaestner</surname><given-names>K. H.</given-names></name><name><surname>Knöchel</surname><given-names>W.</given-names></name><name><surname>Martínez</surname><given-names>D. E.</given-names></name></person-group> (<year>2000</year>). <article-title>Unified nomenclature for the winged helix/forkhead transcription factors</article-title>. <source/>Genes Dev.
<volume>14</volume>, <fpage>142</fpage>–<lpage>146</lpage>. <pub-id pub-id-type="doi">10.1101/gad.14.2.142</pub-id><pub-id pub-id-type="pmid">10702024</pub-id></mixed-citation>
</ref>
<ref id="B38">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lai</surname><given-names>C. S.</given-names></name><name><surname>Fisher</surname><given-names>S. E.</given-names></name><name><surname>Hurst</surname><given-names>J. A.</given-names></name><name><surname>Vargha-Khadem</surname><given-names>F.</given-names></name><name><surname>Monaco</surname><given-names>A. P.</given-names></name></person-group> (<year>2001</year>). <article-title>A forkhead-domain gene is mutated in a severe speech and language disorder</article-title>. <source/>Nature
<volume>413</volume>, <fpage>519</fpage>–<lpage>523</lpage>. <pub-id pub-id-type="doi">10.1038/35097076</pub-id><pub-id pub-id-type="pmid">11586359</pub-id></mixed-citation>
</ref>
<ref id="B39">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lawton</surname><given-names>K. J.</given-names></name><name><surname>Wassmer</surname><given-names>T. L.</given-names></name><name><surname>Deitcher</surname><given-names>D. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Conserved role of Drosophila melanogaster FoxP in motor coordination and courtship song</article-title>. <source/>Behav. Brain Res.
<volume>268</volume>, <fpage>213</fpage>–<lpage>221</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbr.2014.04.009</pub-id><pub-id pub-id-type="pmid">24747661</pub-id></mixed-citation>
</ref>
<ref id="B40">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Le Fevre</surname><given-names>A. K.</given-names></name><name><surname>Taylor</surname><given-names>S.</given-names></name><name><surname>Malek</surname><given-names>N. H.</given-names></name><name><surname>Horn</surname><given-names>D.</given-names></name><name><surname>Carr</surname><given-names>C. W.</given-names></name><name><surname>Abdul-Rahman</surname><given-names>O. A.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>FOXP1 mutations cause intellectual disability and a recognizable phenotype</article-title>. <source/>Am. J. Med. Genet. A
<volume>161</volume>, <fpage>3166</fpage>–<lpage>3175</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36174</pub-id><pub-id pub-id-type="pmid">24214399</pub-id></mixed-citation>
</ref>
<ref id="B41">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lennon</surname><given-names>P. A.</given-names></name><name><surname>Cooper</surname><given-names>M. L.</given-names></name><name><surname>Peiffer</surname><given-names>D. A.</given-names></name><name><surname>Gunderson</surname><given-names>K. L.</given-names></name><name><surname>Patel</surname><given-names>A.</given-names></name><name><surname>Peters</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Deletion of 7q31.1 supports involvement of FOXP2 in language impairment: clinical report and review</article-title>. <source/>Am. J. Med. Genet. A
<volume>143A</volume>, <fpage>791</fpage>–<lpage>798</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31632</pub-id><pub-id pub-id-type="pmid">17330859</pub-id></mixed-citation>
</ref>
<ref id="B42">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Samanta</surname><given-names>A.</given-names></name><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Iacono</surname><given-names>K. T.</given-names></name><name><surname>Brennan</surname><given-names>P.</given-names></name><name><surname>Chatila</surname><given-names>T. A.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>FOXP3 is a homo-oligomer and a component of a supramolecular regulatory complex disabled in the human XLAAD/IPEX autoimmune disease</article-title>. <source/>Int. Immunol.
<volume>19</volume>, <fpage>825</fpage>–<lpage>835</lpage>. <pub-id pub-id-type="doi">10.1093/intimm/dxm043</pub-id><pub-id pub-id-type="pmid">17586580</pub-id></mixed-citation>
</ref>
<ref id="B43">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Weidenfeld</surname><given-names>J.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name></person-group> (<year>2004a</year>). <article-title>Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions</article-title>. <source/>Mol. Cell. Biol.
<volume>24</volume>, <fpage>809</fpage>–<lpage>822</lpage>. <pub-id pub-id-type="doi">10.1128/mcb.24.2.809-822.2004</pub-id><pub-id pub-id-type="pmid">14701752</pub-id></mixed-citation>
</ref>
<ref id="B44">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Lu</surname><given-names>M. M.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name></person-group> (<year>2004b</year>). <article-title>Advanced cardiac morphogenesis does not require heart tube fusion</article-title>. <source/>Science
<volume>305</volume>, <fpage>1619</fpage>–<lpage>1622</lpage>. <pub-id pub-id-type="doi">10.1126/science.1098674</pub-id><pub-id pub-id-type="pmid">15361625</pub-id></mixed-citation>
</ref>
<ref id="B45">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>M. M.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Yang</surname><given-names>H.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name></person-group> (<year>2002</year>). <article-title>Foxp4: a novel member of the Foxp subfamily of winged-helix genes co-expressed with Foxp1 and Foxp2 in pulmonary and gut tissues</article-title>. <source/>Mech. Dev.
<volume>119</volume>, <fpage>S197</fpage>–<lpage>S202</lpage>. <pub-id pub-id-type="doi">10.1016/s1567-133x(02)00058-3</pub-id><pub-id pub-id-type="pmid">14516685</pub-id></mixed-citation>
</ref>
<ref id="B46">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>MacDermot</surname><given-names>K. D.</given-names></name><name><surname>Bonora</surname><given-names>E.</given-names></name><name><surname>Sykes</surname><given-names>N.</given-names></name><name><surname>Coupe</surname><given-names>A. M.</given-names></name><name><surname>Lai</surname><given-names>C. S.</given-names></name><name><surname>Vernes</surname><given-names>S. C.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits</article-title>. <source/>Am. J. Hum. Genet.
<volume>76</volume>, <fpage>1074</fpage>–<lpage>1080</lpage>. <pub-id pub-id-type="doi">10.1086/430841</pub-id><pub-id pub-id-type="pmid">15877281</pub-id></mixed-citation>
</ref>
<ref id="B47">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Medina</surname><given-names>E.</given-names></name><name><surname>Córdova</surname><given-names>C.</given-names></name><name><surname>Villalobos</surname><given-names>P.</given-names></name><name><surname>Reyes</surname><given-names>J.</given-names></name><name><surname>Komives</surname><given-names>E. A.</given-names></name><name><surname>Ramírez-Sarmiento</surname><given-names>C. A.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>Three-dimensional domain swapping changes the folding mechanism of the forkhead domain of FoxP1</article-title>. <source/>Biophys. J.
<volume>110</volume>, <fpage>2349</fpage>–<lpage>2360</lpage>. <pub-id pub-id-type="doi">10.1016/j.bpj.2016.04.043</pub-id><pub-id pub-id-type="pmid">27276253</pub-id></mixed-citation>
</ref>
<ref id="B48">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname><given-names>E.</given-names></name><name><surname>Colomb</surname><given-names>J.</given-names></name><name><surname>Rybak</surname><given-names>J.</given-names></name><name><surname>Pflüger</surname><given-names>H. J.</given-names></name><name><surname>Zars</surname><given-names>T.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Drosophila FoxP mutants are deficient in operant self-learning</article-title>. <source/>PLoS One
<volume>9</volume>:<fpage>e100648</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0100648</pub-id><pub-id pub-id-type="pmid">24964149</pub-id></mixed-citation>
</ref>
<ref id="B49">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mendoza</surname><given-names>E.</given-names></name><name><surname>Tokarev</surname><given-names>K.</given-names></name><name><surname>Düring</surname><given-names>D. N.</given-names></name><name><surname>Retamosa</surname><given-names>E. C.</given-names></name><name><surname>Weiss</surname><given-names>M.</given-names></name><name><surname>Arpenik</surname><given-names>N.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>Differential Co-expression of FoxP1, FoxP2 and FoxP4 in the Zebra Finch (<italic>Taeniopygia guttata</italic>) song system</article-title>. <source/>J. Comp. Neurol.
<volume>523</volume>, <fpage>1318</fpage>–<lpage>1340</lpage>. <pub-id pub-id-type="doi">10.1002/cne.23731</pub-id><pub-id pub-id-type="pmid">25556631</pub-id></mixed-citation>
</ref>
<ref id="B50">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>J. E.</given-names></name><name><surname>Spiteri</surname><given-names>E.</given-names></name><name><surname>Condro</surname><given-names>M. C.</given-names></name><name><surname>Dosumu-Johnson</surname><given-names>R. T.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2008</year>). <article-title>Birdsong decreases protein levels of FoxP2, a molecule required for human speech</article-title>. <source/>J. Neurophysiol.
<volume>100</volume>, <fpage>2015</fpage>–<lpage>2025</lpage>. <pub-id pub-id-type="doi">10.1152/jn.90415.2008</pub-id><pub-id pub-id-type="pmid">18701760</pub-id></mixed-citation>
</ref>
<ref id="B51">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mizutani</surname><given-names>A.</given-names></name><name><surname>Matsuzaki</surname><given-names>A.</given-names></name><name><surname>Momoi</surname><given-names>M. Y.</given-names></name><name><surname>Fujita</surname><given-names>E.</given-names></name><name><surname>Tanabe</surname><given-names>Y.</given-names></name><name><surname>Momoi</surname><given-names>T.</given-names></name></person-group> (<year>2007</year>). <article-title>Intracellular distribution of a speech/language disorder associated FOXP2 mutant</article-title>. <source/>Biochem. Biophys. Res. Commun.
<volume>353</volume>, <fpage>869</fpage>–<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2006.12.130</pub-id><pub-id pub-id-type="pmid">17196932</pub-id></mixed-citation>
</ref>
<ref id="B52">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mozzi</surname><given-names>A.</given-names></name><name><surname>Forni</surname><given-names>D.</given-names></name><name><surname>Clerici</surname><given-names>M.</given-names></name><name><surname>Pozzoli</surname><given-names>U.</given-names></name><name><surname>Mascheretti</surname><given-names>S.</given-names></name><name><surname>Guerini</surname><given-names>F. R.</given-names></name><etal></etal></person-group>. (<year>2016</year>). <article-title>The evolutionary history of genes involved in spoken and written language: beyond FOXP2</article-title>. <source/>Sci. Rep.
<volume>6</volume>:<fpage>22157</fpage>. <pub-id pub-id-type="doi">10.1038/srep22157</pub-id><pub-id pub-id-type="pmid">26912479</pub-id></mixed-citation>
</ref>
<ref id="B53">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Murugan</surname><given-names>M.</given-names></name><name><surname>Harward</surname><given-names>S.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name><name><surname>Mooney</surname><given-names>R.</given-names></name></person-group> (<year>2013</year>). <article-title>Diminished FoxP2 levels affect dopaminergic modulation of corticostriatal signaling important to song variability</article-title>. <source/>Neuron
<volume>80</volume>, <fpage>1464</fpage>–<lpage>1476</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2013.09.021</pub-id><pub-id pub-id-type="pmid">24268418</pub-id></mixed-citation>
</ref>
<ref id="B54">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>C. S.</given-names></name><name><surname>Fuller</surname><given-names>C. K.</given-names></name><name><surname>Fordyce</surname><given-names>P. M.</given-names></name><name><surname>Greninger</surname><given-names>A. L.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>DeRisi</surname><given-names>J. L.</given-names></name></person-group> (<year>2013</year>). <article-title>Microfluidic affinity and ChIP-seq analyses converge on a conserved FOXP2-binding motif in chimp and human, which enables the detection of evolutionarily novel targets</article-title>. <source/>Nucleic Acids Res.
<volume>41</volume>, <fpage>5991</fpage>–<lpage>6004</lpage>. <pub-id pub-id-type="doi">10.1093/nar/gkt259</pub-id><pub-id pub-id-type="pmid">23625967</pub-id></mixed-citation>
</ref>
<ref id="B55">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>S.</given-names></name><name><surname>Renfro</surname><given-names>A.</given-names></name><name><surname>Quattrocchi</surname><given-names>C. C.</given-names></name><name><surname>Sheldon</surname><given-names>M.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name></person-group> (<year>2004</year>). <article-title>Reelin promotes hippocampal dendrite development through the VLDLR/ApoER2-Dab1 pathway</article-title>. <source/>Neuron
<volume>41</volume>, <fpage>71</fpage>–<lpage>84</lpage>. <pub-id pub-id-type="doi">10.1016/s0896-6273(03)00819-5</pub-id><pub-id pub-id-type="pmid">14715136</pub-id></mixed-citation>
</ref>
<ref id="B56">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Niu</surname><given-names>S.</given-names></name><name><surname>Yabut</surname><given-names>O.</given-names></name><name><surname>D’Arcangelo</surname><given-names>G.</given-names></name></person-group> (<year>2008</year>). <article-title>The Reelin signaling pathway promotes dendritic spine development in hippocampal neurons</article-title>. <source/>J. Neurosci.
<volume>28</volume>, <fpage>10339</fpage>–<lpage>10348</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1917-08.2008</pub-id><pub-id pub-id-type="pmid">18842893</pub-id></mixed-citation>
</ref>
<ref id="B57">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Olias</surname><given-names>P.</given-names></name><name><surname>Adam</surname><given-names>I.</given-names></name><name><surname>Meyer</surname><given-names>A.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name><name><surname>Gruber</surname><given-names>A. D.</given-names></name></person-group> (<year>2014</year>). <article-title>Reference genes for quantitative gene expression studies in multiple avian species</article-title>. <source/>PLoS One
<volume>9</volume>:<fpage>e99678</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0099678</pub-id><pub-id pub-id-type="pmid">24926893</pub-id></mixed-citation>
</ref>
<ref id="B58">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>O’Roak</surname><given-names>B. J.</given-names></name><name><surname>Deriziotis</surname><given-names>P.</given-names></name><name><surname>Lee</surname><given-names>C.</given-names></name><name><surname>Vives</surname><given-names>L.</given-names></name><name><surname>Schwartz</surname><given-names>J. J.</given-names></name><name><surname>Girirajan</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations</article-title>. <source/>Nat. Genet.
<volume>43</volume>, <fpage>585</fpage>–<lpage>589</lpage>. <pub-id pub-id-type="doi">10.1038/ng.835</pub-id><pub-id pub-id-type="pmid">21572417</pub-id></mixed-citation>
</ref>
<ref id="B59">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Palumbo</surname><given-names>O.</given-names></name><name><surname>D’Agruma</surname><given-names>L.</given-names></name><name><surname>Minenna</surname><given-names>A. F.</given-names></name><name><surname>Palumbo</surname><given-names>P.</given-names></name><name><surname>Stallone</surname><given-names>R.</given-names></name><name><surname>Palladino</surname><given-names>T.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>3p14.1 <italic>de novo</italic> microdeletion involving the FOXP1 gene in an adult patient with autism, severe speech delay and deficit of motor coordination</article-title>. <source/>Gene
<volume>516</volume>, <fpage>107</fpage>–<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2012.12.073</pub-id><pub-id pub-id-type="pmid">23287644</pub-id></mixed-citation>
</ref>
<ref id="B60">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Panaitof</surname><given-names>S. C.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Dong</surname><given-names>H.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2010</year>). <article-title>Language-related Cntnap2 gene is differentially expressed in sexually dimorphic song nuclei essential for vocal learning in songbirds</article-title>. <source/>J. Comp. Neurol.
<volume>518</volume>, <fpage>1995</fpage>–<lpage>2018</lpage>. <pub-id pub-id-type="doi">10.1002/cne.22318</pub-id><pub-id pub-id-type="pmid">20394055</pub-id></mixed-citation>
</ref>
<ref id="B61">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pariani</surname><given-names>M. J.</given-names></name><name><surname>Spencer</surname><given-names>A.</given-names></name><name><surname>Graham</surname><given-names>J. M.</given-names><suffix>Jr.</suffix></name><name><surname>Rimoin</surname><given-names>D. L.</given-names></name></person-group> (<year>2009</year>). <article-title>A 785 kb deletion of 3p14.1p13, including the <italic>FOXP1</italic> gene, associated with speech delay, contractures, hypertonia and blepharophimosis</article-title>. <source/>Eur. J. Med. Genet.
<volume>52</volume>, <fpage>123</fpage>–<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejmg.2009.03.012</pub-id><pub-id pub-id-type="pmid">19332160</pub-id></mixed-citation>
</ref>
<ref id="B62">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perumal</surname><given-names>K.</given-names></name><name><surname>Dirr</surname><given-names>H. W.</given-names></name><name><surname>Fanucchi</surname><given-names>S.</given-names></name></person-group> (<year>2015</year>). <article-title>A single amino acid in the hinge loop region of the FOXP forkhead domain is significant for dimerisation</article-title>. <source/>Protein J.
<volume>34</volume>, <fpage>111</fpage>–<lpage>121</lpage>. <pub-id pub-id-type="doi">10.1007/s10930-015-9603-4</pub-id><pub-id pub-id-type="pmid">25724387</pub-id></mixed-citation>
</ref>
<ref id="B63">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petkov</surname><given-names>C. I.</given-names></name><name><surname>Jarvis</surname><given-names>E. D.</given-names></name></person-group> (<year>2012</year>). <article-title>Birds, primates and spoken language origins: behavioral phenotypes and neurobiological substrates</article-title>. <source/>Front. Evol. Neurosci.
<volume>4</volume>:<fpage>12</fpage>. <pub-id pub-id-type="doi">10.3389/fnevo.2012.00012</pub-id><pub-id pub-id-type="pmid">22912615</pub-id></mixed-citation>
</ref>
<ref id="B64">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfenning</surname><given-names>A. R.</given-names></name><name><surname>Hara</surname><given-names>E.</given-names></name><name><surname>Whitney</surname><given-names>O.</given-names></name><name><surname>Rivas</surname><given-names>M. V.</given-names></name><name><surname>Wang</surname><given-names>R.</given-names></name><name><surname>Roulhac</surname><given-names>P. L.</given-names></name><etal></etal></person-group>. (<year>2014</year>). <article-title>Convergent transcriptional specializations in the brains of humans and song-learning birds</article-title>. <source/>Science
<volume>346</volume>:<fpage>1256846</fpage>. <pub-id pub-id-type="doi">10.1126/science.1256846</pub-id><pub-id pub-id-type="pmid">25504733</pub-id></mixed-citation>
</ref>
<ref id="B65">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pierrou</surname><given-names>S.</given-names></name><name><surname>Hellqvist</surname><given-names>M.</given-names></name><name><surname>Samuelsson</surname><given-names>L.</given-names></name><name><surname>Enerbäck</surname><given-names>S.</given-names></name><name><surname>Carlsson</surname><given-names>P.</given-names></name></person-group> (<year>1994</year>). <article-title>Cloning and characterization of seven human forkhead proteins: binding site specificity and DNA bending</article-title>. <source/>EMBO J.
<volume>13</volume>, <fpage>5002</fpage>–<lpage>5012</lpage>. <pub-id pub-id-type="pmid">7957066</pub-id></mixed-citation>
</ref>
<ref id="B650">
<mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>R Core Team</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <source/>R: A Language and Environment for Statistical Computing.
<publisher-loc>Vienna, Austria</publisher-loc>: <publisher-name>R Foundation for Statistical Computing</publisher-name>.</mixed-citation>
</ref>
<ref id="B66">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rice</surname><given-names>G. M.</given-names></name><name><surname>Raca</surname><given-names>G.</given-names></name><name><surname>Jakielski</surname><given-names>K. J.</given-names></name><name><surname>Laffin</surname><given-names>J. J.</given-names></name><name><surname>Iyama-Kurtycz</surname><given-names>C. M.</given-names></name><name><surname>Hartley</surname><given-names>S. L.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Phenotype of <italic>FOXP2</italic> haploinsufficiency in a mother and son</article-title>. <source/>Am. J. Med. Genet. A
<volume>158A</volume>, <fpage>174</fpage>–<lpage>181</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.34354</pub-id><pub-id pub-id-type="pmid">22106036</pub-id></mixed-citation>
</ref>
<ref id="B67">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodenas-Cuadrado</surname><given-names>P.</given-names></name><name><surname>Ho</surname><given-names>J.</given-names></name><name><surname>Vernes</surname><given-names>S. C.</given-names></name></person-group> (<year>2014</year>). <article-title>Shining a light on <italic>CNTNAP2</italic>: complex functions to complex disorders</article-title>. <source/>Eur. J. Hum. Genet.
<volume>22</volume>, <fpage>171</fpage>–<lpage>178</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2013.100</pub-id><pub-id pub-id-type="pmid">23714751</pub-id></mixed-citation>
</ref>
<ref id="B68">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roll</surname><given-names>P.</given-names></name><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>Bruneau</surname><given-names>N.</given-names></name><name><surname>Cillario</surname><given-names>J.</given-names></name><name><surname>Ponsole-Lenfant</surname><given-names>M.</given-names></name><name><surname>Massacrier</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2010</year>). <article-title>Molecular networks implicated in speech-related disorders: FOXP2 regulates the SRPX2/uPAR complex</article-title>. <source/>Hum. Mol. Genet.
<volume>19</volume>, <fpage>4848</fpage>–<lpage>4860</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddq415</pub-id><pub-id pub-id-type="pmid">20858596</pub-id></mixed-citation>
</ref>
<ref id="B69">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rousso</surname><given-names>D. L.</given-names></name><name><surname>Pearson</surname><given-names>C. A.</given-names></name><name><surname>Gaber</surname><given-names>Z. B.</given-names></name><name><surname>Miquelajauregui</surname><given-names>A.</given-names></name><name><surname>Li</surname><given-names>S.</given-names></name><name><surname>Portera-Cailliau</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Foxp-mediated suppression of N-cadherin regulates neuroepithelial character and progenitor maintenance in the CNS</article-title>. <source/>Neuron
<volume>74</volume>, <fpage>314</fpage>–<lpage>330</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2012.02.024</pub-id><pub-id pub-id-type="pmid">22542185</pub-id></mixed-citation>
</ref>
<ref id="B70">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname><given-names>M. E.</given-names></name><name><surname>Athanasiadis</surname><given-names>A.</given-names></name><name><surname>Leitão</surname><given-names>A. B.</given-names></name><name><surname>DuPasquier</surname><given-names>L.</given-names></name><name><surname>Sucena</surname><given-names>E.</given-names></name></person-group> (<year>2011</year>). <article-title>Alternative splicing and gene duplication in the evolution of the FoxP gene sub-family</article-title>. <source/>Mol. Biol. Evol.
<volume>28</volume>, <fpage>237</fpage>–<lpage>247</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msq182</pub-id><pub-id pub-id-type="pmid">20651048</pub-id></mixed-citation>
</ref>
<ref id="B71">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schulz</surname><given-names>S. B.</given-names></name><name><surname>Haesler</surname><given-names>S.</given-names></name><name><surname>Scharff</surname><given-names>C.</given-names></name><name><surname>Rochefort</surname><given-names>C.</given-names></name></person-group> (<year>2010</year>). <article-title>Knock-down of FoxP2 alters spine density in Area X of the Zebra Finch</article-title>. <source/>Genes Brain Behav.
<volume>9</volume>, <fpage>732</fpage>–<lpage>740</lpage>. <pub-id pub-id-type="doi">10.1111/j.1601-183x.2010.00607.x</pub-id><pub-id pub-id-type="pmid">20528955</pub-id></mixed-citation>
</ref>
<ref id="B72">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shriberg</surname><given-names>L. D.</given-names></name><name><surname>Ballard</surname><given-names>K. J.</given-names></name><name><surname>Tomblin</surname><given-names>J. B.</given-names></name><name><surname>Duffy</surname><given-names>J. R.</given-names></name><name><surname>Odell</surname><given-names>K. H.</given-names></name><name><surname>Williams</surname><given-names>C. A.</given-names></name></person-group> (<year>2006</year>). <article-title>Speech, prosody and voice characteristics of a mother and daughter with a 7;13 translocation affecting FOXP2</article-title>. <source/>J. Speech Lang. Hear. Res.
<volume>49</volume>, <fpage>500</fpage>–<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1044/1092-4388(2006/038)</pub-id><pub-id pub-id-type="pmid">16787893</pub-id></mixed-citation>
</ref>
<ref id="B73">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>W.</given-names></name><name><surname>Cho</surname><given-names>J. Y.</given-names></name><name><surname>Jiang</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>M.</given-names></name><name><surname>Weisz</surname><given-names>D.</given-names></name><name><surname>Elder</surname><given-names>G. A.</given-names></name><etal></etal></person-group>. (<year>2005</year>). <article-title>Altered ultrasonic vocalization in mice with a disruption in the Foxp2 gene</article-title>. <source/>Proc. Natl. Acad. Sci. U S A
<volume>102</volume>, <fpage>9643</fpage>–<lpage>9648</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0503739102</pub-id><pub-id pub-id-type="pmid">15983371</pub-id></mixed-citation>
</ref>
<ref id="B74">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shu</surname><given-names>W.</given-names></name><name><surname>Lu</surname><given-names>M. M.</given-names></name><name><surname>Zhang</surname><given-names>Y.</given-names></name><name><surname>Tucker</surname><given-names>P. W.</given-names></name><name><surname>Zhou</surname><given-names>D.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name></person-group> (<year>2007</year>). <article-title>Foxp2 and Foxp1 cooperatively regulate lung and esophagus development</article-title>. <source/>Development
<volume>134</volume>, <fpage>1991</fpage>–<lpage>2000</lpage>. <pub-id pub-id-type="doi">10.1242/dev.02846</pub-id><pub-id pub-id-type="pmid">17428829</pub-id></mixed-citation>
</ref>
<ref id="B75">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sin</surname><given-names>C.</given-names></name><name><surname>Li</surname><given-names>H.</given-names></name><name><surname>Crawford</surname><given-names>D. A.</given-names></name></person-group> (<year>2015</year>). <article-title>Transcriptional regulation by FOXP1, FOXP2, and FOXP4 Dimerization</article-title>. <source/>J. Mol. Neurosci.
<volume>55</volume>, <fpage>437</fpage>–<lpage>448</lpage>. <pub-id pub-id-type="doi">10.1007/s12031-014-0359-7</pub-id><pub-id pub-id-type="pmid">25027557</pub-id></mixed-citation>
</ref>
<ref id="B76">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Li</surname><given-names>B.</given-names></name><name><surname>Xiao</surname><given-names>Y.</given-names></name><name><surname>Chen</surname><given-names>C.</given-names></name><name><surname>Wang</surname><given-names>Q.</given-names></name><name><surname>Liu</surname><given-names>Y.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Structural and biological features of FOXP3 dimerization relevant to regulatory T cell function</article-title>. <source/>Cell Rep.
<volume>1</volume>, <fpage>665</fpage>–<lpage>675</lpage>. <pub-id pub-id-type="doi">10.1016/j.celrep.2012.04.012</pub-id><pub-id pub-id-type="pmid">22813742</pub-id></mixed-citation>
</ref>
<ref id="B77">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Song</surname><given-names>X.</given-names></name><name><surname>Tang</surname><given-names>Y.</given-names></name><name><surname>Wang</surname><given-names>Y.</given-names></name></person-group> (<year>2016</year>). <article-title>Genesis of the vertebrate FoxP subfamily member genes occurred during two ancestral whole genome duplication events</article-title>. <source/>Gene
<volume>588</volume>, <fpage>156</fpage>–<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/j.gene.2016.05.019</pub-id><pub-id pub-id-type="pmid">27188254</pub-id></mixed-citation>
</ref>
<ref id="B78">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spaeth</surname><given-names>J. M.</given-names></name><name><surname>Hunter</surname><given-names>C. S.</given-names></name><name><surname>Bonatakis</surname><given-names>L.</given-names></name><name><surname>Guo</surname><given-names>M.</given-names></name><name><surname>French</surname><given-names>C. A.</given-names></name><name><surname>Slack</surname><given-names>I.</given-names></name><etal></etal></person-group>. (<year>2015</year>). <article-title>The FOXP1, FOXP2 and FOXP4 transcription factors are required for islet alpha cell proliferation and function in mice</article-title>. <source/>Diabetologia
<volume>58</volume>, <fpage>1836</fpage>–<lpage>1844</lpage>. <pub-id pub-id-type="doi">10.1007/s00125-015-3635-3</pub-id><pub-id pub-id-type="pmid">26021489</pub-id></mixed-citation>
</ref>
<ref id="B79">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiteri</surname><given-names>E.</given-names></name><name><surname>Konopka</surname><given-names>G.</given-names></name><name><surname>Coppola</surname><given-names>G.</given-names></name><name><surname>Bomar</surname><given-names>J.</given-names></name><name><surname>Oldham</surname><given-names>M.</given-names></name><name><surname>Ou</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>Identification of the transcriptional targets of FOXP2, a gene linked to speech and language, in developing human brain</article-title>. <source/>Am. J. Hum. Genet.
<volume>81</volume>, <fpage>1144</fpage>–<lpage>1157</lpage>. <pub-id pub-id-type="doi">10.1086/522237</pub-id><pub-id pub-id-type="pmid">17999357</pub-id></mixed-citation>
</ref>
<ref id="B80">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stroud</surname><given-names>J. C.</given-names></name><name><surname>Wu</surname><given-names>Y.</given-names></name><name><surname>Bates</surname><given-names>D. L.</given-names></name><name><surname>Han</surname><given-names>A.</given-names></name><name><surname>Nowick</surname><given-names>K.</given-names></name><name><surname>Paabo</surname><given-names>S.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Structure of the forkhead domain of FOXP2 bound to DNA</article-title>. <source/>Structure
<volume>14</volume>, <fpage>159</fpage>–<lpage>166</lpage>. <pub-id pub-id-type="doi">10.1016/j.str.2005.10.005</pub-id><pub-id pub-id-type="pmid">16407075</pub-id></mixed-citation>
</ref>
<ref id="B81">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Takahashi</surname><given-names>K.</given-names></name><name><surname>Liu</surname><given-names>F. C.</given-names></name><name><surname>Oishi</surname><given-names>T.</given-names></name><name><surname>Mori</surname><given-names>T.</given-names></name><name><surname>Higo</surname><given-names>N.</given-names></name><name><surname>Hayashi</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>Expression of FOXP2 in the developing monkey forebrain: comparison with the expression of the genes FOXP1, PBX3, and MEIS2</article-title>. <source/>J. Comp. Neurol.
<volume>509</volume>, <fpage>180</fpage>–<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1002/cne.21740</pub-id><pub-id pub-id-type="pmid">18461604</pub-id></mixed-citation>
</ref>
<ref id="B82">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teramitsu</surname><given-names>I.</given-names></name><name><surname>Kudo</surname><given-names>L. C.</given-names></name><name><surname>London</surname><given-names>S. E.</given-names></name><name><surname>Geschwind</surname><given-names>D. H.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2004</year>). <article-title>Parallel FoxP1 and FoxP2 expression in songbird and human brain predicts functional interaction</article-title>. <source/>J. Neurosci.
<volume>24</volume>, <fpage>3152</fpage>–<lpage>3163</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.5589-03.2004</pub-id><pub-id pub-id-type="pmid">15056695</pub-id></mixed-citation>
</ref>
<ref id="B83">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teramitsu</surname><given-names>I.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name></person-group> (<year>2006</year>). <article-title>FoxP2 regulation during undirected singing in adult songbirds</article-title>. <source/>J. Neurosci.
<volume>26</volume>, <fpage>7390</fpage>–<lpage>7394</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.1662-06.2006</pub-id><pub-id pub-id-type="pmid">16837586</pub-id></mixed-citation>
</ref>
<ref id="B84">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teufel</surname><given-names>A.</given-names></name><name><surname>Wong</surname><given-names>E. A.</given-names></name><name><surname>Mukhopadhyay</surname><given-names>M.</given-names></name><name><surname>Malik</surname><given-names>N.</given-names></name><name><surname>Westphal</surname><given-names>H.</given-names></name></person-group> (<year>2003</year>). <article-title>FoxP4, a novel forkhead transcription factor</article-title>. <source/>Biochim. Biophys. Acta
<volume>1627</volume>, <fpage>147</fpage>–<lpage>152</lpage>. <pub-id pub-id-type="doi">10.1016/s0167-4781(03)00074-5</pub-id><pub-id pub-id-type="pmid">12818433</pub-id></mixed-citation>
</ref>
<ref id="B85">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname><given-names>C. K.</given-names></name><name><surname>Schwabe</surname><given-names>F.</given-names></name><name><surname>Schoof</surname><given-names>A.</given-names></name><name><surname>Mendoza</surname><given-names>E.</given-names></name><name><surname>Gampe</surname><given-names>J.</given-names></name><name><surname>Rochefort</surname><given-names>C.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Young and intense: FoxP2 immunoreactivity in Area X varies with age, song stereotypy, and singing in male zebra finches</article-title>. <source/>Front. Neural Circuits
<volume>7</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.3389/fncir.2013.00024</pub-id><pub-id pub-id-type="pmid">23450800</pub-id></mixed-citation>
</ref>
<ref id="B86">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Toma</surname><given-names>C.</given-names></name><name><surname>Hervás</surname><given-names>A.</given-names></name><name><surname>Torrico</surname><given-names>B.</given-names></name><name><surname>Balmaña</surname><given-names>N.</given-names></name><name><surname>Salgado</surname><given-names>M.</given-names></name><name><surname>Maristany</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2013</year>). <article-title>Analysis of two language-related genes in autism: a case-control association study of FOXP2 and CNTNAP2</article-title>. <source/>Psychiatr. Genet.
<volume>23</volume>, <fpage>82</fpage>–<lpage>85</lpage>. <pub-id pub-id-type="doi">10.1097/YPG.0b013e32835d6fc6</pub-id><pub-id pub-id-type="pmid">23277129</pub-id></mixed-citation>
</ref>
<ref id="B87">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vargha-Khadem</surname><given-names>F.</given-names></name><name><surname>Gadian</surname><given-names>D. G.</given-names></name><name><surname>Copp</surname><given-names>A.</given-names></name><name><surname>Mishkin</surname><given-names>M.</given-names></name></person-group> (<year>2005</year>). <article-title>FOXP2 and the neuroanatomy of speech and language</article-title>. <source/>Nat. Rev. Neurosci.
<volume>6</volume>, <fpage>131</fpage>–<lpage>138</lpage>. <pub-id pub-id-type="doi">10.1038/nrn1605</pub-id><pub-id pub-id-type="pmid">15685218</pub-id></mixed-citation>
</ref>
<ref id="B88">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>MacDermot</surname><given-names>K. D.</given-names></name><name><surname>Monaco</surname><given-names>A. P.</given-names></name><name><surname>Fisher</surname><given-names>S. E.</given-names></name></person-group> (<year>2009</year>). <article-title>Assessing the impact of FOXP1 mutations on developmental verbal dyspraxia</article-title>. <source/>Eur. J. Hum. Genet.
<volume>17</volume>, <fpage>1354</fpage>–<lpage>1358</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2009.43</pub-id><pub-id pub-id-type="pmid">19352412</pub-id></mixed-citation>
</ref>
<ref id="B89">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>Newbury</surname><given-names>D. F.</given-names></name><name><surname>Abrahams</surname><given-names>B. S.</given-names></name><name><surname>Winchester</surname><given-names>L.</given-names></name><name><surname>Nicod</surname><given-names>J.</given-names></name><name><surname>Groszer</surname><given-names>M.</given-names></name><etal></etal></person-group>. (<year>2008</year>). <article-title>A functional genetic link between distinct developmental language disorders</article-title>. <source/>N. Engl. J. Med.
<volume>359</volume>, <fpage>2337</fpage>–<lpage>2345</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa0802828</pub-id><pub-id pub-id-type="pmid">18987363</pub-id></mixed-citation>
</ref>
<ref id="B90">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>Nicod</surname><given-names>J.</given-names></name><name><surname>Elahi</surname><given-names>F. M.</given-names></name><name><surname>Coventry</surname><given-names>J. A.</given-names></name><name><surname>Kenny</surname><given-names>N.</given-names></name><name><surname>Coupe</surname><given-names>A. M.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Functional genetic analysis of mutations implicated in a human speech and language disorder</article-title>. <source/>Hum. Mol. Genet.
<volume>15</volume>, <fpage>3154</fpage>–<lpage>3167</lpage>. <pub-id pub-id-type="doi">10.1093/hmg/ddl392</pub-id><pub-id pub-id-type="pmid">16984964</pub-id></mixed-citation>
</ref>
<ref id="B91">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>Oliver</surname><given-names>P. L.</given-names></name><name><surname>Spiteri</surname><given-names>E.</given-names></name><name><surname>Lockstone</surname><given-names>H. E.</given-names></name><name><surname>Puliyadi</surname><given-names>R.</given-names></name><name><surname>Taylor</surname><given-names>J. M.</given-names></name><etal></etal></person-group>. (<year>2011</year>). <article-title>Foxp2 regulates gene networks implicated in neurite outgrowth in the developing brain</article-title>. <source/>PLoS Genet.
<volume>7</volume>:<fpage>e1002145</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pgen.1002145</pub-id><pub-id pub-id-type="pmid">21765815</pub-id></mixed-citation>
</ref>
<ref id="B92">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vernes</surname><given-names>S. C.</given-names></name><name><surname>Spiteri</surname><given-names>E.</given-names></name><name><surname>Nicod</surname><given-names>J.</given-names></name><name><surname>Groszer</surname><given-names>M.</given-names></name><name><surname>Taylor</surname><given-names>J. M.</given-names></name><name><surname>Davies</surname><given-names>K. E.</given-names></name><etal></etal></person-group>. (<year>2007</year>). <article-title>High-throughput analysis of promoter occupancy reveals direct neural targets of FOXP2, a gene mutated in speech and language disorders</article-title>. <source/>Am. J. Hum. Genet.
<volume>81</volume>, <fpage>1232</fpage>–<lpage>1250</lpage>. <pub-id pub-id-type="doi">10.1086/522238</pub-id><pub-id pub-id-type="pmid">17999362</pub-id></mixed-citation>
</ref>
<ref id="B93">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Lin</surname><given-names>D.</given-names></name><name><surname>Li</surname><given-names>C.</given-names></name><name><surname>Tucker</surname><given-names>P.</given-names></name></person-group> (<year>2003</year>). <article-title>Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors</article-title>. <source/>J. Biol. Chem.
<volume>278</volume>, <fpage>24259</fpage>–<lpage>24268</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M207174200</pub-id><pub-id pub-id-type="pmid">12692134</pub-id></mixed-citation>
</ref>
<ref id="B94">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>B.</given-names></name><name><surname>Weidenfeld</surname><given-names>J.</given-names></name><name><surname>Lu</surname><given-names>M. M.</given-names></name><name><surname>Maika</surname><given-names>S.</given-names></name><name><surname>Kuziel</surname><given-names>W. A.</given-names></name><name><surname>Morrisey</surname><given-names>E. E.</given-names></name><etal></etal></person-group>. (<year>2004</year>). <article-title>Foxp1 regulates cardiac outflow tract, endocardial cushion morphogenesis and myocyte proliferation and maturation</article-title>. <source/>Development
<volume>131</volume>, <fpage>4477</fpage>–<lpage>4487</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01287</pub-id><pub-id pub-id-type="pmid">15342473</pub-id></mixed-citation>
</ref>
<ref id="B95">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Whitney</surname><given-names>O.</given-names></name><name><surname>Voyles</surname><given-names>T.</given-names></name><name><surname>Hara</surname><given-names>E.</given-names></name><name><surname>Chen</surname><given-names>Q.</given-names></name><name><surname>White</surname><given-names>S. A.</given-names></name><name><surname>Wright</surname><given-names>T. F.</given-names></name></person-group> (<year>2015</year>). <article-title>Differential <italic>FoxP2</italic> and <italic>FoxP1</italic> expression in a vocal learning nucleus of the developing budgerigar</article-title>. <source/>Dev. Neurobiol.
<volume>75</volume>, <fpage>778</fpage>–<lpage>790</lpage>. <pub-id pub-id-type="doi">10.1002/dneu.22247</pub-id><pub-id pub-id-type="pmid">25407828</pub-id></mixed-citation>
</ref>
<ref id="B96">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeesman</surname><given-names>S.</given-names></name><name><surname>Nowaczyk</surname><given-names>M. J.</given-names></name><name><surname>Teshima</surname><given-names>I.</given-names></name><name><surname>Roberts</surname><given-names>W.</given-names></name><name><surname>Cardy</surname><given-names>J. O.</given-names></name><name><surname>Brian</surname><given-names>J.</given-names></name><etal></etal></person-group>. (<year>2006</year>). <article-title>Speech and language impairment and oromotor dyspraxia due to deletion of 7q31 that involves FOXP2</article-title>. <source/>Am. J. Med. Genet. A
<volume>140</volume>, <fpage>509</fpage>–<lpage>514</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.31110</pub-id><pub-id pub-id-type="pmid">16470794</pub-id></mixed-citation>
</ref>
<ref id="B97">
<mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Žilina</surname><given-names>O.</given-names></name><name><surname>Reimand</surname><given-names>T.</given-names></name><name><surname>Zjablovskaja</surname><given-names>P.</given-names></name><name><surname>Männik</surname><given-names>K.</given-names></name><name><surname>Männamaa</surname><given-names>M.</given-names></name><name><surname>Traat</surname><given-names>A.</given-names></name><etal></etal></person-group>. (<year>2012</year>). <article-title>Maternally and paternally inherited deletion of 7q31 involving the <italic>FOXP2</italic> gene in two families</article-title>. <source/>Am. J. Med. Genet. A
<volume>158A</volume>, <fpage>254</fpage>–<lpage>256</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.34378</pub-id><pub-id pub-id-type="pmid">22105961</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>